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Diclofenac, a non-steroidal anti-inflammatory drug used as a human pharmaceutical and a 
veterinary medicine has been identified as a priority emerging organic compound. Diclofenac 
has been detected within waterways globally at low ng-µg/L concentrations. While 
diclofenac has been shown to be toxic to aquatic organisms, there is currently a lack of data 
on the toxicity of diclofenac to endemic New Zealand fish species. A current limitation of 
ecotoxicity studies is the cost and workload associated with determining exposure 
concentrations. Cheap and robust alternative extraction methods need to be developed.  This 
study developed a method of passive sampling using nylon filters to extract diclofenac from 
water samples. Extraction recoveries of diclofenac were concentration dependent and there 
was no effect of pH on recovery. Average recoveries for diclofenac for 0.05 and 500 µg/L 
were 103% and 58% respectively. The toxicity of diclofenac on the common bully was 
investigated in a concentration-dependent and a salinity dependent manner. Exposure 
concentrations for diclofenac were 0, 0.1, and 1000 µg/L and the salinities tested were 0, 6, 
and 20‰. The biochemical endpoints used for determination of toxicity were 
ethoxyresorufin-O-deethylase, glutathione-S-transferase and protein carbonylation. Overall, 





4’-OHD 4-hydroxy diclofenac  
5’-OHD 5-hydroxy diclofenac 
AcN Acetylnitrile  
BCA Bicinchoninic acid 




CTR Control temperature room 
CYP450 Cytochrome P450 
DCM Dichloromethane 
DNPH 2,4-Dinitrophenylhydrazine 
EC50 Effective concentration 50% 
EDTA Ethylenediaminetetraacetic acid 
EE2 Ethinyl estradiol 
EIS Electron impact spectra 
EME Electromembrane extraction 
EOCs Emerging organic contaminants 
EROD Ethoxyresorufin-O-deethylase 
GC-MS Gas chromatography mass-spectrometry  





H2O2 Hydrogen peroxide 
H2SO4 Sulphuric acid 
HC HEPEs Cortland buffer  
HPLC High performance liquid chromatography 
LC50 Lethal concentration 50% 
LD50 Lethal dose 50% 
LLE. Liquid-liquid extraction 




NSAIDs Non-steroidal anti-inflammatory drugs 
O2- Oxide ion 
OH· Hydroxyl ion   
PAHs Polycyclic aromatic hydrocarbons 
PCBs Polychlorinated biphenyl 
PDA Photodiode array 
PFTBA Perfluorotributylamin 
PPCPs Pharmaceuticals and personal care products 
QA/QC. Quality assurance/Quality control 
ROS Reactive oxygen species 
SBME. Solid bar micro-extraction 
SCX Strong cation exchange 
SIM Selected ion mode 
SOD Superoxide dismutase 
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SPE. Solid phase extraction 
SPME. Solid phase micro-extraction 
SUPRAS. Supramolecular solvent 
TCA Trichloroacetic acid 
UV. Ultra violet 















Emerging organic contaminants (EOCs) are compounds not routinely monitored for in the 
environment and include chemicals that can be classified as “pharmaceuticals and personal 
care products (PPCPs)” (Richardson et al. 2005). These are products designed for human or 
veterinary use but which find their way into the environment primarily through waste water. 
To a large degree their presence in the environment is due to waste water treatment plants 
(WWTPs) not adequately removing these chemicals from sewerage. Unfortunately, even 
though the majority of the compounds have short chemical half-lives, they are permanently 
present within waterways because of continual entry into the environment (Boyd et al. 2003). 
Given that these are chemicals designed to be biologically active, their pseudo-persistence in 
the environment raises concerns regarding their impact on aquatic species (Jiang et al. 2014) .  
While the presence of EOCs in the aquatic environment is of growing concern, but our 
understanding of environmental concentrations, and especially impacts on aquatic biota, is 
limited.  Aquatic organisms such as fish are continuously exposed to the contaminants, and 
owing to their biology are especially at risk. Fish utilise their gills for a multitude of critical 
functions, including oxygen uptake, nitrogenous waste excretion and osmoregulation (Evans 
et al. 2005). To facilitate these processes, the gill has a very high surface area, a very thin 
diffusive distance, and a flow of water is constantly passed over the gill to maintain the 
diffusive gradients that drive its functions. However, these properties also exacerbate its 
exposure to waterborne contaminants. A higher exposure will lead to greater accumulation, 
and enhanced toxicological impact (Blewett et al. 2013). This property makes fish 
particularly sensitive to environmental toxicants and therefore makes them ideal organisms to 
study the effects of EOCs. As such fish play an important role in regulatory settings, where 
impacts on fish can be used to determine safe levels of contaminants in the environment  (Lin 
et al. 2015). 
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1.2 Emerging organic contaminants 
The EOCs are a group of compounds composed primarily of anthropogenic chemicals 
that are present in the environment. Examples of EOCs include, but are not limited to, 
veterinary products, pesticides, and PPCPs such as analgesics/anti-inflammatories, 
antibiotics, cardiovascular pharmaceuticals (β-blockers/diuretics), psycho-stimulants, 
oestrogens and hormonal compounds, and anti-epileptic drugs (Kanda et al. 2003). These are 
chemicals that have not been routinely monitored or tested for in the environment. With 
advances in analytical chemistry and emerging evidence of their impacts on non-target biota, 
EOCs are increasingly the focus of research to provide new information on their entry into 
the environment as well as their toxicity (Kennish 2002).   
The presence of EOCs within the environment is of concern due to the potential for 
adverse effects on non-target species through prolonged exposure at low concentrations (Lee 
et al. 2012).   However, despite the growing awareness of EOC’s and their potential risk, 
there is only limited data regarding environmental concentrations and biological impacts.  For 
example, knowledge of EOC levels are largely restricted to the United States (Boyd et al. 
2004), Canada (Lissemore et al. 2006), the United Kingdom (Kasprzyk-Hordern et al. 2008), 
China (Peng et al. 2008), and small European countries considered popular holiday 
destinations (Kuster et al. 2008; Oliva et al. 2014). That leaves large regions of the globe 
under- or un-represented in terms of knowledge of the levels of EOCs present. Furthermore, 
it is important to highlight that many of these studies focus in on a small subset of the total 
EOCs that may be present. It is even more difficult to find data that has examined the 
biological impacts of these contaminants on aquatic biota. While some studies will assess the 
presence of EOC’s in a given aquatic setting, they will not follow up on possible 
toxicological effects (Hao et al. 2007; Wu et al. 2008). Further work is required to identify 
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the presence and concentrations of EOCs, including PPCP’s, in other areas of the world, as 
well as looking at their impact on endogenous species.  
One EOC for which there is growing knowledge of both environmental concentrations 
and biological impacts is ethinyloestradiol (EE2), an estrogenic compound used as an oral 
contraceptive (Endrikat et al. 1997). EE2 appears in the aquatic environment in part through 
improper disposal of pills. Alternatively, EE2 may be metabolised and excreted from the 
human body appearing in a conjugated form in WWTP effluents. However, in the 
environment it is converted back to EE2 by microbial activity (Ying et al. 2002). Many 
studies have reported findings supporting the negative impact of EE2 on aquatic species. For 
example, increased vitellogenin (a precursor of yolk protein), a lack of sexual differentiation, 
and feminisation of male fish have been observed (Lange et al. 2001; Örn et al. 2003; Parrott 
et al. 2005). These changes can have devastating impacts on populations. In one study 
experimental dosing of low levels of EE2 resulted in the complete elimination of fish from an 
EE2 treated lake within a few years (Nash et al. 2004; Filby et al. 2007; Kidd et al. 2007).  
EE2 is one of the best-studied PCPP’s, but there is increasing recognition of the 
importance of other such chemicals in aquatic environments. One group of interest are the 
non-steroidal anti-inflammatory drugs (NSAIDs). These are widely used in human and 
veterinary health as pain relief medications, but they also represent an important class of 
EOC that present in increasing concentrations in the environment (Angela Yu-Chen et al. 
2005; Murray et al. 2010).  The NSAIDs include drugs such as aspirin (salicylate) and 
ibuprofen, the most common pain relief medication worldwide. However, one NSAID, 





1.3.1 Diclofenac as a pharmaceutical 
Diclofenac (2-[-2′,6′-(dichlorophenyl)amino]phenyl acetic acid), is a NSAID that is 
used worldwide as a human pharmaceutical and a veterinary medicine (Green et al. 2004). It 
is primarily used to treat inflammatory diseases, but is also recommended as pain relief for 
menstrual cramps, migraines, as well as a variety of muscle aches and pains (Tiwari et al. 
2015).  In humans, severe side effects of diclofenac include an increased chance of serious 
cardiovascular thrombotic events, myocardial infarction, stroke, stomach ulceration and renal 
failure (Chan et al. 2002). 
Diclofenac causes its pharmacological effects through the inhibition of the 
cyclooxygenase (COX) enzyme. This enzyme is responsible for the synthesis of 
prostaglandins that are signalling molecules used for a wide variety of biological functions, 
including inflammation and the induction of pain (Vane et al. 1998). Diclofenac binds to both 
COX-1 and COX-2 isoforms, preventing the conversion of arachidonic acid to pro-
inflammatory prostaglandins and thereby reducing inflammation (Kirchheiner et al. 2003). 
The inhibition of COX-2 results in a reduction of inflammation and pain relief, whereas 
inhibition of COX-1 results in an increased chance of gastrointestinal distress (Silverstein et 
al. 2000). Diclofenac is thought to bind more favourably to COX-2 than other NSAID’s 
resulting in it being a more commonly dispensed NSAID  for inflammatory illnesses (Mancy 
et al. 1999). 
Diclofenac is metabolised in the liver and has two primary metabolites. The major 
metabolite is 4’-hydroxy-diclofenac (4’-OHD) while 5-hydroxy-diclofenac (5-OHD) is also 
produced but at lower concentrations (Lee et al. 2012). Studies have shown the cytochrome 
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P450 enzymes CYP2C9 and CYP3A4 to be primarily responsible for the conversion of 
diclofenac to 4’-OHD and 5-OHD, respectively (Yasar et al. 2001; Thörn et al. 2011).  
Diclofenac is sold under a number of trade names (Voltaren, Cataflam, Zorvolex, and 
Zipsor) with the most well-known being Voltaren. Within New Zealand, diclofenac is 
dispensed in two forms: a tablet for general pain relief, and a gel for targeted pain relief and it 
the 18th most frequently prescribed drug in New Zealand (PHARMAC). Diclofenac is able to 
be obtained without prescription in most parts of the world, and thus is sold over-the-counter 
in supermarkets and pharmacies. The exception to this is the USA and the UK where 
diclofenac is a prescription drug (Moore 2007; Hug et al. 2012). Due to its accessibility, 
diclofenac is commonly used in households to treat bumps and bruises, sports injuries, as 
well as on-going muscular pains. The gel is preferred for long term use as there are fewer 
adverse side effects associated with it, in comparison to the oral dose (Mester et al. 2002). 
This is reflected in reported usage rates across countries where it is used and sold in large 





   
Table 1. 1: Comparison of diclofenac consumption and diclofenac sold between 1998 and 
2008 in a variety of countries 
 










Mijatovic et al. (2011) 
2006 43.1  
2007 49.4  
2008 42.1  
 
Croatia 
2005 16.5  
2006 20.3  
2007 14.8  
2008 13.5  
 
Denmark 
2005 19.9  
2006 20.7  
2007 21.4  
2008 22.3  
Australia 1998 - 4.4 Khan et al. (2004) 
England 2000 - 26.1 Jones et al. (2002) 
Germany 1999 - 250 Scheytt et al. (2005)1 
                                                          




1.3.2 Diclofenac as an EOC 
The two forms of diclofenac have different routes of entry into aquatic environments. 
When taken orally. 65% of the dose, as well as metabolites, are excreted. While some of this 
will be retained within the WWTP system, most enters the environment (Lienert et al. 2007). 
The topical form of diclofenac enters the environment as the pure compound owing to the 
mechanism of application. The gel is often rubbed onto the site of pain with excess gel being 
washed off and entering the household waste water (Kasprzyk-Hordern et al. 2008).  
Diclofenac is not fully removed during wastewater treatment, resulting in entry into the 
environment via sewerage (Hartmann et al. 2008). Diclofenac has been recently placed on a 
watch list for regulation under the European Water Framework Directive due to its extensive 
presence in waterways and the reported toxicity on aquatic organisms (Acuña et al. 2015).  
Research has shown diclofenac is detected in waterways across Europe, Asia, and the 
Americas (Table 1.2) at concentrations up to 1800 ng/L. Concentrations vary from study to 
study, likely owing to factors such as: analytical techniques used to determine diclofenac, 
population densities and rates of diclofenac consumption, the specific WWTP processes at 
each location, and water body dilution.  
With the growing interest in the environmental impacts of PCPPs in the aquatic 
environment, there has been a need to develop new methods that facilitate the measurement 
of these chemicals in water (Cleuvers 2003; Ferrari et al. 2003; Santos et al. 2010). Many 
studies use solid phase extraction (SPE), liquid-liquid extraction or their micro counterparts 
(Farré et al. 2007; Zhou et al. 2014; Toledo-Neira et al. 2015). These are valid techniques that 
result in high extraction rates as they have been refined for pharmaceutical extraction (Wu et 
al. 2008). The issue with these techniques is that they require a laboratory setting for analysis 
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of samples. Passive sampling using filters is a technique that is being refined and modified as 
it allows for direct sampling of water sources allowing for in-field extraction (Nyoni et al. 
2010). This reduces the need for transporting of water samples to the laboratory in which 
time degradation is occurring, instead giving accurate real time concentrations (Wille et al. 
2011). This thesis develops a method for passive sampling using nylon filters to extract 
diclofenac from exposure water samples to determine whether it is a viable method for 
extracting diclofenac from water samples generated in ecotoxicity testing. 
 




Water source Reference 
Germany 1300-3300  WWTP Stülten et al. (2008) 
Pakistan 400-1800  River Scheurell et al. (2009) 
Slovenia 9-282  River Kosjek et al. (2005) 




Comeau et al. (2008) 
Taiwan 2  Surface seawater Jiang et al. (2014) 
USA 2.5  WWTP Vidal-Dorsch et al. (2012) 
UK <8-195  Estuary Thomas et al. (2004) 
Portugal 0.18  Sea Paíga et al. (2015) 




Noche et al. (2011) 




In New Zealand, no studies have been carried out to detect the presence of diclofenac in 
local waters. Given that diclofenac is one of the most frequently prescribed drugs in New 
Zealand and is also available over the counter it would be expected that diclofenac would be 
present in waterbodies receiving WWTP effluents. Due to the absence of research within 
New Zealand, studies need to be carried out to investigate the presence of diclofenac in the 
aquatic environment and its impact on local aquatic species (refer to Section 1.5). 
1.3.3 Environmental chemistry of diclofenac 
1.3.4 Diclofenac and biochemical effects 
1.3.4.1  Effects on cytochrome P450 activity 
Cytochrome P450s (CYP450) are a class of more than 50 different enzymes, with well-
characterised endogenous roles in the production of steroids, cholesterol, bile acids and 
eicosanoid signalling chemicals (Miners et al. 1998). CYP450 enzymes are also well known 
for their role in drug metabolism as Phase 1 detoxification enzymes (Guo et al. 2014). 
Consequently, as described above, CYP450s are responsible for the breakdown of diclofenac 
(Bort et al. 1999).  Upon exposure to this, and other organic chemicals, CYP activity can be 
induced. This occurs via a mechanism that involves a xenosensor, such as the aryl 
hydrocarbon receptor (Bass et al. 2009). Once activated this sensor will induce CYP activity, 
so that the organism can deal with the influx of drug or toxicant. Induction of CYP activity by 
diclofenac has been noted in the literature (Lauer et al. 2009).  
The induction of CYP450 is a useful biomarker of exposure to organic contaminants, 
especially within aquatic species (Lopes et al. 2011; Burkina et al. 2012). Such contaminants 
include chlorinated dibenzo-p-dioxins, dibenzofurans, polycyclic aromatic hydrocarbons 
(PAHs), and planar polychlorinated biphenyls (PCBs). All these contaminants induce 
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CYP450 activity in fish tissues following environmental exposure (Ricciardi et al. 2006). 
Diclofenac has also been shown to induce CYP activity in fish (Mehinto et al. 2010).  
1.3.4.2 Diclofenac and effects on Phase II metabolism.  
 Once a drug or toxicant has undergone oxidation by the CYP enzymes, it is common 
for Phase II metabolism to occur. This phase involves the conjugation of the metabolite with 
a chemical group, making the metabolite more soluble, and able to be excreted (Zamek-
Gliszczynski et al. 2006). There are a series of different enzymes that are responsible for 
Phase II metabolism, including UDP glucuronosyltransferases, N-acetyltransferases, and 
glutathione S transferase (GST) (Willett et al. 2000). Like for Phase I enzymes, Phase II 
pathways can be upregulated by exposure to toxicants. For example, GST has been shown to 
be induced by a number of pharmaceuticals and organic toxicants (Xu et al. 2005), including 
diclofenac (Khanduja et al. 1997).  
1.3.4.3  Oxidative stress markers 
One common mechanism of toxicity shared among a variety of different toxicant classes 
is the induction of oxidative stress  (Lushchak 2011). Oxidative stress is the result of an 
imbalance between reactive oxygen species (ROS) and the antioxidant systems of the body. 
Metabolic processes are responsible for the formation of certain ROS such as hydrogen 
peroxide (H2O2), superoxide radical (O2
-) and the hydroxyl radical (OH·) anion (Malanga et 
al. 2004). Reactive oxygen species cause toxicity through binding to proteins, lipids and 
DNA/RNA. Due to their reactive nature, they bind to the DNA bases causing structural 
alterations that go on to affect translation and transcription resulting in inhibition of protein 
and enzyme formation (Wiseman et al. 1996; Valko et al. 2005). Diclofenac has been known 
to cause oxidative damage through binding to lipids resulting in an increase in lipid 
peroxidation (Gomez-Olivan et al. 2014) 
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Countering the ROS are a number of anti-oxidant mechanisms that act to scavenge ROS 
before they can cause damage. These include the activities of the enzymes superoxide 
dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX; Oviedo-Gomez, 2009). 
Consequently, oxidative stress can be measured as either an increase in ROS that cause 
effects, an increase in oxidative damage, or as a change in the activity of anti-oxidant defence 
mechanisms. Diclofenac has been known to react with glutathione (GSH) indicating it is 
metabolised to prevent damage to cells. Hepatic protein adducts have been detected in liver 
cells in mice resulting in the diclofenac-GSH conjugate becoming a useful biomarker for the 
hepatotoxicity of diclofenac (Grillo et al. 2003). 
1.3.5 Diclofenac toxicity 
1.3.5.1 General toxicity 
The ability of diclofenac to act as an environmental toxicant was first shown by 
studies that showed severe impacts of this drug on vultures. From 1992 until 2007, there was 
a significant decline in vulture numbers in Asia. Among the affected species, the white-
rumped vulture (Gyps bengalensis) showed a 99.9% population decline while populations of 
the Indian vulture (Gyps indicus) and the slender-billed vulture (Gyps tenulrostris) declined 
by 95% (Swan et al. 2006a). Analysis of vulture carcasses found that a major factor in this 
decline was diclofenac. The diclofenac was used as veterinary pain relief on farmed cattle. 
When the cattle died, they were left in the fields to be consumed by the vultures (Cuthbert et 
al. 2011). The LD50 (dose that causes 50% mortality in the population) of diclofenac for 
vultures is considered to be between 98 and 225 µg/kg, making diclofenac a Class 1 (the most 
severe class) toxic compound for vultures. This lead to diclofenac manufacturing being 
banned in India, Pakistan, and Nepal in 2006 (Taggart et al. 2009).  
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 Studies have investigated the toxicity of diclofenac on differing fish species to 
determine the median lethal concentration (LC50), median effect concentration (EC50) and the 
median lethal dose at 50% (LD50). Diclofenac has been recorded as having an LC50 of 166.6 ± 
9.8 mg/L in juvenile zebrafish (Danio rerio) and an LC50 of 6.11 ± 2.48 mg/L in embryos of 
the same species (Praskova et al. 2011). The LC50 of diclofenac for the African catfish 
(Clarias gariepinus) was lower than that for the zebrafish at 25.12 mg/L (Ajima et al. 2015). 
Regarding the EC50, a dose of 6 ng egg
-1 was found to affect half of the population in medaka 
fish (Oryzias latipes) embryos (Nassef et al. 2010). The EC50 was determined for two cell 
lines of rainbow trout (Oncorhynchus mykiss) hepatocytes with concentrations of 19 µM and 
420 µM effecting half of the cells exposed (Laville et al. 2004). The EC50 of diclofenac in 
zebrafish embryos was recorded as 5.3 mg/L (van den Brandhof et al. 2010). In summary, 
diclofenac is known to be toxic to fish species, however toxicity differs between species as 
well as age. Hence further studies need to be carried out to determine the toxicity of 
diclofenac on the common bully as the values cannot often be compared across species. 
1.3.5.2 Effect of salinity on toxicity 
Salinity is an environmental factor that exerts significant influence over the function of 
aquatic biota. Osmoregulating organisms such as fish, must maintain an internal osmotic 
concentration in spite of fluctuations in external osmotic concentrations. In freshwater, fish 
are more concentrated than their surrounds are thus constantly faced with diffusive ion loss, 
and water gain, and thus to maintain salt and water balance must actively take up ions and 
excrete excess water (Evans et al., 2005). These tasks are principally achieved by the gills 
and the kidneys, respectively. In marine settings the opposite occurs, with diffusive ion gain 
and water loss (Evans et al., 2005). In seawater the gill is again the principal tissue associated 
with regulating ion transport, and fish also drink in order to balance water loss. Because of 
the differences in physiology, there can be significant differences in the toxicological impacts 
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of a contaminant, depending on whether the organism is in freshwater or seawater. For 
example, drinking in seawater will expose the gut to waterborne contaminants, potentially 
increasing the sites of absorption and thus toxicity.  Such an effect has been observed in fish 
exposed to the organic toxicant naphthalene (Levitan et al. 1979). It is also important to note 
that the different water chemistry between freshwaters and seawaters may also influence the 
chemical form of a toxicant, and thus salinity may also impact toxicity in this manner (Glover 
et al. 2016).  
Because of the important potential influence of salinity on toxicant effect, research is now 
investigating the effect of salinity on toxicity of pharmaceutical compounds. For example, 
one study has examined the impact of ibuprofen and salicylate exposure on the 
hyposmoregulatory capacity of rainbow trout. Salicylate, and to a lesser degree, ibuprofen 
both disrupted corticosteroidogenesis, which impacts the acclimation of fish to seawater 
(Gravel et al. 2009). Understanding how environmental variables such as salinity impact 
uptake and toxicity of diclofenac is crucial to protecting aquatic organisms. Such data are of 
particular relevance as many of the receiving environments where diclofenac will eventually 
end up will be impacted by salinity.   
1.4 Methods for determining toxicity 
When determining the effects of environmental contaminants on aquatic species there are 
two main approaches used: field-based biomonitoring and laboratory-based exposures. 
Biomonitoring is where organisms are obtained from the wild and analysis of animal health 
and/or body burdens of contaminants provides results directly relevant to environmental 
levels of contaminants. Biomonitoring can therefore provide information of the impact of 
pollutants on natural populations (Lu et al. 2013). Exposures involve laboratory experiments 
where organisms are exposed to contaminants of known concentration under controlled 
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environmental conditions (e.g. temperature, flow rate, pH, salinity; (Bostrom et al. 2015). In 
these experiments acute and chronic toxicities are able to be tested, and mechanisms of 
toxicant effect can be isolated from confounding influences of the environment (Lee et al. 
2011; Galus et al. 2013). These studies therefore provide data that can be used to predict 
environmental effects and help determine the impact of compounds of concern (Munoz et al. 
2008; Kosma et al. 2014). Eventually such data can be used by regulators to place restrictions 
on the level of contamination of specific compounds in the environment (Sayeed et al. 2003). 
1.5 New Zealand fish 
In New Zealand there are approximately 66 freshwater species, over 1,000 marine species 
and 270 coastal species of fish, with approximately 40%, 11% and 25% of the species being 
endemic, respectively. Some of the species have required conservation care in the form of 
marine reserves to maintain population numbers and diversity (Davidson et al. 2002). A high 
rate of endemism means that many of the fish species at risk from environmental 
contamination in New Zealand do not feature in overseas studies as they are only found in 
New Zealand where there is a notable lack of research regarding diclofenac as a contaminant. 
As regulatory tools are based on model Northern hemisphere species (Stockin et al. 2007), it 
means that if there are significant differences in sensitivity between well-studied overseas 
species and New Zealand fish, then New Zealand fish may not be protected by regulations.  
1.5.1 Common bully 
The common bully is a freshwater fish species endemic to New Zealand and is a member 
of the Gobiidae family. It is one of seven species of the Gobiomorphus genus found across 
New Zealand. The other 6 are the giant bully (G. gobioides), the Cran’s bully (G. basalis), 
the upland bully (G. breviceps), the redfin bully (G. huttoni), Tarndale bully (G. alpinus), and 
the bluegill bully (G. hubbsi) (Department of Conservation 2016). The common bully is a 
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small fish, reaching a maximum length of 15 cm and weighing no more than 16 g at maturity. 
It has a blunted head, a solid body and two dorsal fins. Their body colour ranges from light- 
to mid-brown depending on habitat and light exposure, with males obtaining a black 
colouration during mating season. During spawning, the females lays eggs that are orange in 
colour, with the eggs being laid on any hard surface. The males will fertilise the eggs forming 
territories that they then protect (Rowe 1996).  
The common bully is amphidromous. This is a type of diadromy that involves hatching in 
estuarine waters, followed by a migration from fresh to salt water during the larval stage, 
before a return to freshwater (Michel et al. 2008).  The migratory period during the larval 
stage is not obligatory, meaning some fish will reach maturity in freshwater sources (Hicks 
2012). Studies show that these non-migratory fish are more commonly found in inland water 
sources, while the diadromous members of the species are found closer to the sea. Due to its 
amphidromous nature, the common bully can be found in marine, brackish, and freshwater 
environments making it an ideal organism in which to examine the impacts of salinity on 
toxicity. 
The common bully is a demersal species, being commonly found in the water column just 
above, or on, the river or sea bed where it feeds on invertebrates. It prefers rivers and streams 
that are shallow with a swift current and cover (Jowett et al. 1995). These waterways are 
likely to come in contact with diclofenac as they are often found near estuaries and 
wastewater outputs. The common bully is also present in many urban streams, which may be 
subjected to domestic runoff (Kostarelos et al. 2010).  
1.5.2 Previous toxicology studies using the common bully 
The common bully has previously been used New Zealand toxicology studies. For 
example, van den Heuvel et al. (2007) used the common bully to monitor the impacts of pulp 
and paper effluent in the Tarawera River in New Zealand. It was determined that there was an 
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impact on spawning season, where spawning occurred in winter rather than spring. It was 
concluded that this was a genetic impact rather than one relating to effluent exposure. 
However, these authors attributed the genetic impact to effluent exposure, by suggesting that 
the effluent exposure was high enough in early years of pulp milling to diminish the 
downstream population causing a genetic bottleneck 
However, some studies have shown that the bully is impacted by environmental pollution. 
For example, exposure to pulp and paper effluents was shown to result in changes in 
reproductive physiological function in this species (Bleackley 2008). Specifically, a depletion 
of carotenoid pigments and a disruption of follicular steroid biosynthetic capacity in females 
was observed (Bleackley 2008).   
1.6 Research rationale 
. There is a lack of knowledge regarding the impact of diclofenac on native fish species in 
New Zealand. The common bully is saline tolerant and is found in locations where diclofenac 
could occur (coastal streams, urban waterways). Because of this, developing a method for 
practical sampling in the field is essential. Passive sampling can be used to obtain real-time 
values present in the environment as well as useful in lab practices regarding cost efficiency. 
Based on previous research it is known that exposure of fish to diclofenac results in changes 
in Phase I and II metabolism, and that oxidative stress is an impacted end-point. Changes in 
these end-points over short-term exposures can be indicative of long-term toxic impacts 
(Scholz et al. 2008). Diclofenac is an important contaminant to consider due to it proving to 
be toxic to aquatic species and being prevalent in waterways. It has already greatly impacted 
the vulture species in India and more work is being carried out to determine its impact on 





1.7 Aims  
The aims of this thesis were to; 
 Develop an extraction technique that is cost- and time-effective for extracting 
diclofenac from water samples collected from ecotoxicity assays. 
 To test for a range of biochemical endpoints to determine the effect of diclofenac on 
the common bully. 
 
1.8 Thesis structure 
This thesis is broken down into five chapters. Following this general Introduction 
(Chapter 1), Chapter 2 describes the chemical and biological methods used throughout the 
following chapters. Chapter 3 outlines the development of a method for determining 
diclofenac in water. This passive filter-based method, coupled with advanced chemical 
analysis is shown to be an effective method for detection of low level, environmental, 
concentrations of diclofenac in water. Chapter 4 describes a study examining mechanisms of 
diclofenac toxicity to the common bully looking at the effects of dose and water salinity. It 
shows that the common bully displays changes in biochemistry that trend towards those 
observed in other studied fish species. A general discussion and conclusion to this thesis can 
be found in Chapter 5 that summarises the experimental chapters and places this work in a 









This chapter outlines the methods used in this thesis, including fish capture and 
acclimation, glassware cleaning procedures, diclofenac exposures, biochemical assays, 
analysis of water samples, and statistical analysis. Each sub-section outlines the preparation 
of reagents and provides an overview of the method. All procedures involving fish carried out 
were approved by the University of Canterbury Animal Ethics Committee. 
 
2.1. Sampling sites and method capture 
Collections of the common bully (Gobiomorphus cotidianus) were carried out 
between the months of July and September 2015 from Lake Ellesmere. Fish were collected at 
a site just off of Timber Yard Road (-43.797404, 172.370574). Lake Ellesmere is a large 
brackish lake south of Christchurch, which at the time of collection had an average salinity of 
6.9‰. Approximately 70 fish were caught using a 6 m long drag net. The fish were 
transported back to the university in lidded buckets with bubblers inserted to keep the water 
oxygenated. The buckets were secured in the truck to prevent excess movement. The weights 
and lengths of the fish caught were 5.83 ± 2.55 g (mean ± standard error of the mean; SEM) 
and 8.05 ± 1.34 cm (mean ± SEM), respectively.  
 
2.2. Acclimation 
At the University of Canterbury, fish were held at 15°C, under a light regime of 14 h 
light: 10 h dark, with dawn and dusk transitions. Fish were subjected to three distinct salinity 
conditions through the course of the thesis (freshwater, 6‰, and 20‰). Fish used in the 
freshwater exposures were held in plastic 80 L tanks with approximately 24 fish per tank. 
These tanks were supplied with flow-through freshwater a flow rate of approximately 10 
mL/min. The freshwater had the following water chemistry: pH 7.1; total hardness 0.7 
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mmol/L; total alkalinity 0.519 mmol/L; electrical conductivity 18.8 mS/m; Ca 0.57 mmol/L; 
Mg 0.14 mmol/L; K 0.29 mmol/L; Na 0.37 mmol/L; Cl 0.31 mmol/L; dissolved organic 
carbon (DOC) <0.2 mg C/L. The tanks were checked daily to monitor the flow of water, 
cleanliness of the tanks, and the health of the fish. Fish were fed to satiation every three days 
using Nutrafin Max fish food flakes, with excess food removed the day after feeding. Fish 
were not fed two days prior to, nor for the duration of, exposures. These freshwater fish were 
held in the tanks for a minimum of 7 days before use in an exposure.   
Following collection, two groups of fish were immediately subjected to salinity 
acclimation. These fish (collected at 6.9‰), were held in tanks under conditions identical to 
those described above, but with static-renewal water flow conditions. The group to be used at 
6‰ were immediately transferred to water with a salinity of approximately 6‰, and held for 
21 days. Complete water changes were conducted every 3 days. For the second group, after 
three days being held at 6‰, water in the tank was completely replaced with water at a 
salinity of 10‰. This process of water changes and salinity increases (3 to 4‰ per change) 
was repeated every 3 days until a final salinity of 20‰ was attained. Fish in both salinity-
acclimation groups were held for a minimum of two weeks before use in an exposure. 
Salinity was adjusted by addition of natural seawater (collected from Lyttelton Harbour at 
sites seen in Figure 2 below). At a salinity of 6‰ the water chemistry was: pH 7.2; Na 98 
mmol/L; Ca 3 mmol/L; Mg 11 mmol/L; K 2 mmol/L; DOC <0.2 mg C/L, while at 20‰ the 
water chemistry was: pH 7.6; Na 325 mmol/L; Ca 9 mmol/L; Mg 37 mmol/L; K 8 mmol/L; 
DOC 0.3 mg C/L.  The feeding regime for salinity-acclimated fish was the same as for those 
kept in freshwater. 
2.3. Glassware preparation 
The glassware used for the exposures (tanks used to hold fish during experimentation, 
bottles containing diclofenac solutions, and lidded jars used to hold water samples) were acid 
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washed in 14% nitric acid for a minimum of 24 hours to minimise contamination. They were 
then rinsed clean using deionised water and left to air dry for approximately 24 hours. Once 
dry, they were then rinsed in triplicate with each of High Performance Liquid 
Chromatography (HPLC) grade dichloromethane (DCM), methanol (MeOH), and acetonitrile 
(AcN) resulting in a total of 9 rinses. These were left to dry overnight before use. 
All glassware used for water analysis, HPLC, and Gas Chromatography- Mass 
Spectrometry (GC-MS) sample preparation (including Schott bottles, measuring cylinders, 
volumetric flasks, funnels, storage bottles and vials) were left overnight in a detergent bath 
and then rinsed using tap water and left overnight to air dry. They then underwent three 
MeOH rinses, followed by three DCM rinses, and three AcN rinses, with any residual solvent 
left to evaporate off in a fume hood overnight before use. Glassware was cleaned in this 
manner in between every use. GC-MS glassware had to be MeOH free before use to prevent 
interference with the derivatisation agent (N-Methyl-N-(trimethylsilyl) trifluoroacetamide; 
MSTFA). 
2.4. Diclofenac exposures 
2.4.1.  Diclofenac dosing 
Stock solutions were used to dose the water used in the exposures. Three dosing 
solutions were prepared. A 500 mg/L solution was prepared by dissolving 0.1345 g of 
diclofenac in 250 mL of Milli-Q water (> 18 MΩ). The 500 mg/L stock was diluted with 
Milli-Q to prepare 10 mg/L and 50 µg/L dosing solutions. The 500 mg/L and the 50 µg/L 
solutions were added to 2 L of water in 4 mL volumes to obtain final concentrations of 1000 
µg/L and 0.1 µg/L respectively. The 0 µg/L control was obtained by using a clean measuring 





2.4.2.  Concentration-dependent effects of diclofenac 
Exposures were carried out in a controlled temperature room (CTR) set to 12 ± 1 °C 
in 3 L amber glass tanks, cleaned as described above (Section 2.3). To minimise diclofenac 
degradation, exposures were conducted in the dark, with red light used when necessary. Air 
lines were inserted into each exposure chamber to facilitate aeration. Exposures were carried 
out in 2 L of aquarium freshwater. Three diclofenac concentrations were used: 0 µg/L 
(control), 0.1 µg/L (environmental mimic), and 1000 µg/L (effect level). Diclofenac was 
added to exposure waters for 24 hours before fish were added to allow equilibration. The 
stock solutions of diclofenac (see Section 2.4.1) were stored in the CTR in 4-L lidded amber 
bottles for 24 hours before use. Each exposure concentration had eight replicates (fish), with 
1 fish per exposure tank. 
 Exposures were conducted for 96 h, with water changes at 48 h using solutions that 
had been equilibrated for 24 h, as above. Water samples were taken from the exposure tanks 
at four time points for chemistry analysis (see Sections 2.6.2 and 2.6.4): 0 h, 48 h before the 
water change, 48 h after the water change, and 96 h. Samples were taken by filling a 100 mL 
amber lidded jar to the brim with water from the exposure tank. Gloves were worn while 
carrying out water sampling to minimise contamination. Samples were processed 
immediately and kept covered to avoid potential photodegradation (refer to Section 2.6.1). 
 
2.4.3.  Effect of salinity on diclofenac toxicity 
These experiments were conducted under the same environmental conditions as those 
described in Section 2.4.2, with the exception of the salinity of the exposure water (0‰, 6‰ 
and 20‰) and that just two diclofenac concentrations were examined (0 and 1000 µg/L). The 
96 h exposure was conducted identically to those described for concentration-dependent 
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exposures, with stock solution handling, water pre-equilibration, water changes, and water 
sampling for diclofenac conducted as previously detailed. 
2.4.4.  Tissue sampling protocol 
At the end of exposures, fish were euthanised by anaesthetic overdose (1 g/L tricaine 
methanosulfate, Sigma Aldrich), followed by severing of the spinal cord. Each fish was 
individually measured for body weight (± 0.01 g) and total length (± 1.0 mm). Gills were 
removed immediately after euthanasia and used directly for ethoxyresorufin O-deethylation 
(EROD) analysis (Section 2.5.1). The liver was dissected, wrapped in aluminium foil, flash 
frozen in liquid nitrogen, and then stored at -80°C.  The liver tissue was later used in the 
analysis of oxidative stress markers (glutathione S-transferase assays and protein 
carbonylation; Sections 2.5.2 and 2.5.3).  
 
2.5. Biochemical assays 
2.5.1. Ethoxyresorufin O-deethylation assay  
The EROD assay was based on that described by Jönsson et al. (2003), which utilises 
measurement of the colour change from clear to pink when ethoxyresorufin undergoes O-
deethylation to form resorufin. Briefly, freshly dissected gills were rinsed with HEPES-
Cortland (HC) buffer and then placed into a 12-well cell culture plate containing 2 mL of HC 
buffer per well. The HC buffer composition was as follows:  0.38 g/L KCl, 7.74 g/L NaCl, 
0.23 g/L MgSO4·7H2O, 0.23 g/L CaCl2·2H2O, 0.41 g/L NaH2PO4·H2O, 1.43 g/L HEPES, 1 
g/L glucose, pH 7.7. Approximately 8-10 gill filaments were cut into 2 mm pieces with fine 
scissors to maximise exposure to the buffer. The HC buffer was removed from the wells and 
replaced with 500 µL of reaction buffer. The reaction buffer was prepared by adding 0.5 µL 
of 10-6 M 7-ethoxyresorufin and 0.5 µL of 10-5 M dicumarol to 0.5 mL of HC buffer. The 
volumes of each reagent were adjusted depending on the total volume of reaction buffer 
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required. The gills were left to incubate at room temperature for 10 minutes. After incubation, 
200 µL duplicate samples of reaction buffer were transferred to a Greiner Bio-one non-
binding black bottomed 96-well microplate. The remaining reaction buffer was replaced with 
700 µL of fresh reaction buffer and left to incubate at room temperature for a further 30 
minutes, at which point a further 200 µL sample was transferred to the 96-well plate. 
Duplicates of resorufin standards (obtained from Sigma-Aldrich) ranging from 0 to 250 nm 
were added to generate a calibration curve. This was carried out for every run. Duplicates of 
reaction buffer, and Milli-Q water were added in 200 µL volumes to acts as controls and 
blanks respectively. The samples were run on a plate reader (SpectraMax M5) at an 
excitation wavelength of 544 nm and an emission wavelength of 590 nm.  
To calculate EROD activity, a scatter graph was generated using picomoles of the 
resorufin standards on the x-axis and the fluorescence of the standards on the y-axis. A trend 
line was inserted and the corresponding equation was used to convert fluorescence to an 
amount of resorufin formed (pmol). From the resulting value, the mean ‘blank’ was 
subtracted from each sample to correct for background, and corrected for dilution factor. This 
value was divided by the time period it was incubated for (10 or 30 minutes), and the number 
of filament tips, to give activity values as pmoles of resorufin per filament tip per minute 
(Jonsson et al. 2003). 
 
2.5.2. Glutathione S-transferase assay 
The activity of glutathione S-transferase (GST) was determined by an assay that 
utilises the GST-mediated conjugation of glutathione to 1-chloro-2,4-dinitrobenzene 
(CDNB), and measures the resulting absorbance change at 340 nm (Wilce et al. 1994). GST 
activity was determined via an assay kit purchased from Sigma-Aldrich (CS0410; Sigma-
Aldrich). Before commencing the assay, reagents were prepared. A 10 mL master mix was 
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prepared by mixing 14.7 mL of Dulbecco’s phosphate buffered saline, 0.1 mL of 200 mM 
reduced L-glutathione and 0.1 mL of CDNB together, which was sufficient for 75 assays 
carried out in a 96-well plate. The CDNB and the Dulbecco’s phosphate buffered saline were 
warmed to 25°C before being mixed.  
Liver tissue (approximately 0.09 g) was homogenised for 30 seconds using a plastic 
centrifuge tube homogenisation tool in cold buffer (100 mM Tris-base, 2 mM EDTA, 5 mM 
MgCl2.6H2O, pH 7). Into a 96-well plate, duplicates 4 µL controls of provided GST,  
triplicate 20 µL samples of homogenised liver, and duplicate 200 µL blanks of master mix 
were added to individual wells. Master mix was added to the samples and controls to make 
the total volume up to 200 µL. The plate was gently shaken to mix the components before 
being run on the plate reader. The absorbance was set to detect wavelengths at 340 nm. The 
samples ran for 6 minutes while shaking, with readings taken every minute. 
A trend line was fitted to a calibration curve and the equation obtained from it 
produced the absorbance per minute value (∆A340/min) for each sample. To obtain the 
∆A340/min value for the blank, the highest A340 obtained over the six minutes was subtracted 
from the initial A340
 (the lowest absorbance value), and this was then divided by the time 
difference between these two values. The ∆A340/min of the blank was then subtracted from 




where V (mL) was the reaction volume used (0.2 mL), dil was the dilution factor of the 
sample, ԐmM (µM/cm) was the extinction coefficient for CDNB conjugate at 340 nm (5.3 
µM), and Venz (mL) was the volume of the enzyme tested (20 µL). The equation produced 
GST specific activity in µmoles per mL/min.  
= µmol/mL/min
   
ΔA340/min x V (mL) x dil 
        ԐµM x Venz (mL) 





2.5.3. Protein carbonylation assay 
The protein carbonylation assay measures the production of stable carbonyl groups 
that form as a result of protein oxidation (Colombo et al. 2016). To determine carbonyl 
content, the assay works on the basis of derivatising protein carbonyl groups using 2, 4-
dinitrophenylhydrazine (DNPH). This results in a colour change from a vivid yellow to a 
colourless solution, which can be monitored spectrophotometrically at 375 nm. The assay 
protocol used was from a kit obtained from Sigma Aldrich (MAK094).  
 Before commencing the assay, the vials containing the reagents were centrifuged 
before being opened. A 10 mL vial of acetone was placed in the freezer at -20°C whilst 
bringing the following reagents to room temperature: DNPH solution, streptozocin solution, 
and 6 M guanidine solution. Homogenised liver samples that were prepared for the GST 
assay were bought to room temperature and centrifuged to remove insoluble material. The 
samples were then diluted with Milli-Q water to reach a protein concentration of 10 mg/mL. 
To ensure there was no interference from nucleic acids, 10 µL of the 10% streptozocin 
solution was added for every 100 µL of sample. Upon addition of the streptozocin, samples 
were left to incubate at room temperature for 15 minutes before being centrifuged at 13,000 x 
g for 5 minutes. The supernatant was transferred to a new tube. For the DNPH assay reaction, 
100 µL of the DNPH solution was added to each supernatant sample. The sample was 
vortexed for approximately 5 seconds before being left to incubate at room temperature for 
10 minutes. After incubation, 30 µL of ice-cold 10% trichloroacetic acid (TCA) solution was 
added to each sample to precipitate the proteins. The sample was vortexed for approximately 
5 seconds before being left to incubate on ice for 5 minutes. Samples were then centrifuged at 
13,000 x g for 2 minutes. The supernatant was carefully removed and discarded. A 500 µL 
volume of ice-cold acetone was added to each pellet to remove excess DNPH before 
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sonicating in a bath for 30 seconds. Post sonication, the sample was left to incubate at -20°C 
for 5 minutes before centrifuging at 13,000 x g for two minutes. The acetone was discarded 
gently using a Pasteur pipette to prevent disturbance of the TCA pellet, removing any free 
DNPH remaining. To the TCA pellet, 200 µL of 6 M guanidine solution was added before 
sonicating for 30 seconds. Once the pellet had re-solubilised, 100 µL of each sample was 
transferred in triplicate to the 96-well plate provided with the kit. Absorbance was measured 
at a wavelength of 375 nm using a microplate reader. 
To determine the amount of carbonyl in the sample well, the following equation was 
used:  
  C = (A375/ ԐmM x λ) x V 
where C is the amount of carbonylation per well (nmole/well), A375 is the corrected sample 
absorbance, ԐmM is the millimolar extinction coefficient (6.364 mM/cm) multiplied by the 
path length in a well (λ; 0.2893 cm) and the 100 represents the total volume (V) in the well 
(100 µL). To then determine the amount of carbonyl per mg of protein, Equation 2.2:  
  
CP (nmol carbonyl/mg protein) = (C/P) x 1,000 x D 
 
Where C is the result of Equation 2.2, P is the amount of protein in the well, D is the dilution 
factor, and 1,000 is the conversion factor (µg to mg). The end result is the concentration of 
protein carbonylation in nmol per mg of protein. 
 
2.5.4. Bradford assay 
The (Bradford 1976) assay is a commonly used protein determination assay. It works 
on the principle of a colour change from brown to blue upon the dye, Brilliant Blue G, 





liver homogenates and standards (bovine serum albumin (BSA); Sigma-Aldrich) were sub-
sampled onto a non-UV clear bottomed 96 well plate in 10 µL aliquots. To each well, 200 µL 
of Bradford reagent (Sigma-Aldrich) was added, and after a 10-minute incubation, 
absorbance was measured on a plate reader at 595 nm. A calibration curve was constructed, 
and protein concentrations of the homogenised liver samples were calculated. This assay was 
used for all protein concentration measurements except those used to standardise the protein 
carbonyl assay (see Section 2.5.5). The Bradford assay was not suitable for protein 
determination in the protein carbonyl assay due to interference from the guanidine in the test 
samples. 
2.5.5. Bicinchoninic acid assay 
To determine protein concentration of the samples run during the protein carbonyl 
assays, a bicinchoninic acid (BCA) assay was performed (BCA1-1KT; Sigma Aldrich). The 
BCA assay works on the basis of a colour change from pale blue/green to purple upon 
proteins reducing Cu (II) to Cu (I) (Huang et al. 2010). Using a 96 well plate, 5 µL of sample 
was transferred along with 200 µL of BCA working reagent. Standards were made from BSA 
as in Section 2.5.4.  Milli-Q water and the buffer used to prepare the homogenised tissue 
(Section 2.5.2) were used as blanks for the standards and samples respectively. The plate was 
left to incubate at 37°C for 30 minutes. The plate was then read at 562 nm using a microplate 





2.6. Analytical protocols 
2.6.1. Diclofenac extraction 
Diclofenac was extracted from water samples using a filter absorption method as 
described in detail in Chapter 3. Water samples of 100 mL volume were transferred to Schott 
bottles, acidified to a pH of 2 using approximately 3 drops of H2SO4, and had a Sartorius 
Biolab 4.8 cm diameter, 0.2 µm nylon membrane filter added. The sample was then covered 
in aluminium foil to protect against photo-degradation and put on a shaker table for 24 hours 
at medium speed. The filter was removed and transferred to a 15 mL amber vial, which was 
then placed on a heating block at 65-100°C to dry. The filter was rinsed three times using 4 
mL of MeOH, and was vortexed during every rinse to ensure maximum extraction of 
diclofenac from the filter and the aliquots of MeOH were combined in a 15 mL amber glass 
vial. The MeOH was then evaporated off under nitrogen at 65°C until dry. The vial was 
rinsed three times with MeOH (500 µL, 250 µL, 250 µL) and the aliquots of MeOH were 
combined in a 15 mL amber glass vial.. 
Each extraction batch (n = 24 samples) included a spiked sample and a Milli-Q blank. 
Two spike concentrations (0.1 and 200 µg/L) were used dependent on the expected sample 
concentration. 
2.6.2. High performance liquid chromatography analysis 
HPLC is an analytical method that separates compounds dissolved in a solvent, based 
on their structure and size due to their interactions with a solid adsorbent column (Kupiec, 
2004). HPLC was used in this project as it is an affordable method of sample detection that 
works well for high environmental concentrations of diclofenac (Nováková et al. 2006). 
2.6.3. High performance liquid chromatography protocol 
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Samples were analysed on a Dionex UltiMate 3000 HPLC fitted with a photodiode 
array (PDA) detector, quaternary pump, mobile phase degasser, and autosampler. The 
column used was a Phenomenex Luna 5u C18 (2) column (150 x 4.60 mm). The mobile 
phase was 60:40 NaH2PO4 buffer, pH 3: acetonitrile, run isocratically at 1 mL per minute. 
Injection volume of the test solution was 20 µL with a total analysis time of 31 minutes per 
sample. Ultra-violet PDA detection of diclofenac was at 240 nm with a retention time of 13.2 
minutes.  
A calibration curve of diclofenac standards was prepared for each run with a 
concentration range of 0 to 2000 µg/mL. The calibration standards were run before and after 
each batch of samples. The 100 and 1000 µg/mL standards, and a blank of AcN were 
analysed after every 10 samples, while every 20 samples a sample was injected in duplicate 
to monitor variability. These samples confirmed the stability and reproducibility of the 
calibration. Calibration curves were linear (R2 = 0.9995) over the calibration concentration 
range. 
 
2.6.4. Gas chromatography–mass spectrometry analysis 
GC-MS is an analytical method that combines two commonly-used techniques to 
successfully separate volatile and semi-volatile compounds while also selectively detecting 
them. Compounds are separated via GC, before being pumped into the MS where they are 
ionised. Upon ionisation, the individual compounds are exposed to a beam of electrons that 
induces fragmentation which results in a determination of mass that can be divided by the 
charge (Fialkov et al. 2007). This allows determination of the molecular weight. Because of 
this specificity, the GC-MS detects compounds at levels as low as sub-nanograms (Sneddon 
et al. 2007). The GC-MS is a popular technique for qualitative and quantitative determination 





The samples prepared in Section 2.6.1 were evaporated until dry under nitrogen at 
80°C and then had 100 µL of AcN added. Standards were made, ranging in concentration 
from 0 to 100 µg/L. To both the standards and the samples, 25 µL of hydroxypyrene (internal 
standard) and 100 µL of MSTFA (derivatisation agent) were added, before being vortexed 
and placed on a heating block at 80°C for 1 hour (Farré et al. 2007).  
 
2.6.6. Analysis of derivatised samples 
The derivatised sample extracts and calibration standards were analysed by GC-MS 
using a Shimadzu GC-2010 Gas Chromatograph, interfaced to a Shimadzu AOC-20i Auto 
Injector and a Shimadzu GCMS-QP2010Plus detector. Instrumental control, data acquisition 
and data processing were performed using the Shimadzu GCMS Solution software (Version 
2.70). Analytes were separated on a Rxi-5Sil column (5% diphenyl/95% dimethyl 
polysiloxane) 30 m x 0.25 mm ID, 0.25 µm film thickness, with an integrated guard column 
(10 m, Integra-Guard) (Restek, Belleftone USA). Derivatised samples and calibration 
standards were injected into the injection port in splitless mode at a temperature of 280°C in 
1 µL volumes. The initial oven temperature of 80°C was held for 1 minute, then increased at 
a rate of 10°C/min to 150°C, then increased at 8°C/min to 215°C, and then increased by 
10°C/min until it reached the final temperature of 280°C. The total run time was 32.63 
minutes. Helium was used as the carrier gas at a flow rate of 5.5 mL/min. 
The ion source was held at 230°C and the GC-MS interface at 280°C. Electron Impact 
Spectra (EIS) were obtained at 70 eV in selected ion mode (SIM). The MS was calibrated 
against perfluorotributylamine (PFTBA) before each sample run using the mass spectrometry 
auto tune function. 
26 
 
 Retention times and mass-to-charge ratios used for detection and quantification of the 
individual compounds were as follows: diclofenac quantifying ion 214, qualifying ions 73, 
367, and 352, retention time 20.91 minutes; hydroxypyrene (the internal standard) 
quantifying ion 290, qualifying ions 275 and 259, retention time 22.65 minutes.  
2.6.7.  Quality assurance/quality control 
To give quality control, controls were run with every exposure. This was to ensure 
there was no contamination of the water used and to make sure the cleaning of the tanks was 
being carried out properly. To provide quality assurance, exposure samples were run in 
duplicate for the first exposure and in triplicate for the following two exposures. Blanks were 
also carried out in duplicate or triplicate respective of the exposure week. 
A water sample spiked with diclofenac was included in every batch to determine 
method recovery. Water blanks were spiked with either 2 mL or 1 mL of diclofenac standard 
(Section 2.4.1) depending on the expected concentration (200 µg/L and 0.1 µg/L 
respectively). These samples then underwent the same extraction process as experimental 
samples.  
Duplicates of samples, high and low standards, and a blank were run during both 
HPLC and GC-MS analyses to ensure stability and reproducibility of results. Standards were 
run before the samples to ensure there was no interference with the readings such as early 
elution or detection of the compound, or excess background noise. The blanks were used to 





2.7 Statistical analysis 
Statistical analysis was carried out using SigmaPlot (ver. 11.2; Systat). Normality of data 
was assessed using Kolmogorov-Smirnov test. Homogeneity of variance was determined 
using Levene’s test. Where necessary, square root and log transformations were performed on 
data so that the assumptions were met for analysis using analysis of variance (ANOVA). In 
Chapter 4, concentration-dependent data underwent parametric one-way ANOVAs and the 
salinity-dependent data underwent two-way ANOVA (with diclofenac concentration and 
water salinity the two factors). For some of the assay data reported in Chapter 4, high 
variability in one of the tested groups was noted. In this scenario, a Student t-test was 
performed in order to reduce the impact of this variability on all comparisons. This test was 
performed as an indicative test only, with the statistical analysis of record being the ANOVA. 
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With the growing interest in the impacts of PCPPs in the aquatic environment, there 
has been a need to develop new methods that facilitate the measurement of these chemicals in 
water (Cleuvers 2003; Ferrari et al. 2003; Santos et al. 2010). Such methods are important not 
only for determining levels in natural waters, but are also critical for laboratory testing, in 
order to confirm levels of exposures, and to ensure that factors such as photodegradation do 
not impact exposure concentrations. The requirement for laboratory studies to report 
measured rather than nominal concentrations can generate large numbers of samples all 
requiring extraction within a relatively short time-frame. There is therefore a need to develop 
cost- and time-efficient methods of extracting and analysing compounds from water samples 
generated in ecotoxicity tests. A range of techniques have been used to extract PPCPs from 
water samples including: liquid-liquid extraction (LLE), liquid phase microextraction 
(LPME), solid-phase extraction (SPE), micro-solid phase extraction (µ-SPE/SPME), and 
solid bar microextraction (SBME). 
Liquid-liquid extraction is a technique that uses an aqueous solution and an 
immiscible organic solvent to extract compounds (Raydo et al. 2015). The water sample is 
shaken with an immiscible solvent in a separating funnel. The resulting mixture is left to 
stand and separate into various layers before the organic solvent is removed and analysed. 
This technique is time intensive and requires large amounts of solvent and equipment (Wells 
2003). Liquid phase microextraction uses a drop of water-immiscible solvent to extract the 
analytes. Exposure of the solvent to the sample can occur directly by dropping the solvent 
into a stirred sample solution, or by stabilising the drop in a hollow fibre (Pedersen-Bjergaard 
et al. 2002; Ouyang et al. 2007). LPME therefore works on a similar principle to LLE but is 
faster and incurs a greatly reduced solvent cost (Larsson et al. 2009). 
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Solid phase extraction involves passing a water sample through a cartridge containing 
an appropriate sorbent under vacuum, followed by elution with organic solvents. This 
technique allows for the concentration of large volumes of water samples. It is commonly 
used as it is a simple, cost-effective and convenient method, however the drawbacks are the 
time intensive sample preparation, low compound selectivity, the impracticality of large 
batches of samples, and the cost of commercial sorbents such as C18 and strong cation 
exchange (SCX; (Vaananen et al. 2000; Gilart et al. 2012; Rezaei et al. 2013). Micro-solid 
phase extraction (also known as solid phase microextraction; µ-SPE or SPME) works along 
the same principles of SPE but with a fused silica fibre that has a stationary phase on the 
outside. This is used to trap the analyte between itself and the matrix of other compounds in 
the sample, increasing specificity beyond that which can be achieved by SPE (Balakrishnan 
et al. 2006).  
Solid bar micro-extraction is a technique that is more time- and solvent-efficient than 
SPE that has been developed for the extraction of pharmaceuticals. It works by packing 
sorbent materials into a small sealed tube. The tube is then placed within the aqueous sample 
and the compounds permeate through the membrane of the tube and bind to the sorbent 
material within. Permeation is increased by the stirring of the solid bar which increases 
contact of the compound to the sorbent. The compounds can then be eluted using solvents 
(Al-Hadithi et al. 2011). 
Multiple techniques have been previously used to extract diclofenac from water 
samples. Of greatest methodological concern is the low environmental levels at which 
diclofenac occurs.  SPME has been used successfully to extract diclofenac from a range of 
matrices and such methods have a detection limit as low as 4 ng/L (Wang et al. 2011). This is 
a time- and cost-effective method with good recovery rates (Pebdani et al. 2015). 
Electromembrane extraction (EME) is another method used that is similar to LPME, where 
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the organic phase is held within the wall of a fibre so that is immobilised. Two electrodes 
produce a charge that induces migration through the wall of the fibre. This technique allows 
for high sensitivity and selectivity of diclofenac (Ramos Payan et al. 2011). Both of these 
techniques are faster and more solvent efficient than SPE (Stuelten et al. 2008; Rezaei et al. 
2013).  
Passive samplers are a form of sampling that occurs in situ in water bodies, and which 
relies on sorption of the analyte to the sampler over time. They are used for analysis of large 
samples of water due to their cost- and time-effectiveness. Once the sampler has been placed 
in the sample, it can be left for any length of time to obtain maximum sorption (Nyoni et al. 
2011).  A disadvantage of this technique is the low specificity and sensitivity due to the large 
volumes it is used for (Nyoni et al. 2010).  Passive samplers are used to obtain time-weighted 
average concentrations of pollutants in field settings and are also used to obtain bioavailable 
levels of pollutants by mimicking biological equilibrium uptake (Mazzella et al. 2010). 
Passive samplers are also used to provide comparison between passively-accumulated 
contaminants and tissue concentrations in aquatic biota collected from similar sites, thus 
providing information on the ability of such organisms to regulate contaminant accumulation 
(Joyce et al. 2015).   
Filter papers have the potential to be used as passive samplers for ecotoxicity tests, as 
laboratory studies have shown that these can remove PPCPs from water samples.  For 
example, one study investigated the absorption of three oestrogen compounds to a range of 
filters to determine the optimal filtration technique to prevent losses due to sorption (Walker 
et al. 2010). The basis of this proposed method is that the compound of interest, in this case 
diclofenac, adsorbs onto a filter while in an aqueous phase. Once adsorbed, the compound 
can be extracted off the filter using a solvent that can be evaporated down, increasing the 
concentration of the compound and thus facilitating analysis. This approach offers a number 
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of significant benefits such as: reduced sorbent cost, in situ application, and time efficiency 
(Vrana et al. 2005). Furthermore, the use of filter s as passive samplers is a relatively 
inexpensive approach, and allows high through-put of samples. 
Passive sampling methods are being investigated to replace or supplement SPE as 
cheaper and faster techniques (Nyoni et al. 2010). Although high recovery can be achieved by 
SPE, there are many steps to prepare one sample for analysis. In comparison, the filter-based 
method being developed is cost-, and time-efficient by removing the need for cartridges using 
only filters instead, as well as reducing the amount of solvent required (Kibbey et al. 2010). 
The limitation on the number of samples that can be extracted is based on glassware 
availability and lab space for shaker tables and sample preparation. 
In the current study a filter-based extraction technique for diclofenac was developed, with 
a specific emphasis on how incubation time, pH, and diclofenac concentration affected 
recovery. For the first of these factors (incubation time), three extraction periods were tested: 
4, 8, and 24 hours. These periods were chosen as being convenient periods given normal 
operating hours within a laboratory setting. There were two pH conditions tested, pH 5.7 and 
pH 2. Diclofenac has a pKa of 4.2 and at a pH 6.0 or greater, diclofenac will be present as an 
anion. As the pH increases, the ionic form becomes more prevalent (Cheng et al. 2015). Thus 
these two pH’s allowed assessment of the effect of diclofenac adsorption while in different 
ionic states.  There were two diclofenac concentrations tested within this study, 0.1 µg/L and 
1000 µg/L. These were chosen as environmental and effect levels, respectively and also 
represent the two concentrations used in the concentration-dependent exposures to common 
bullies (Chapter 4).  
The adapted method used nylon filters supplied by Sartorius Biolab, as this material was 
the most effective in adsorbing the three hormones studied in Walker’s research (Walker et 
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al. 2010). Nylon filters have hydrophilic properties and are resistant to organic solvents, 
making them suitable for sorbing compounds from aqueous solutions in preparation for 
analysis (Han et al. 2010).  
3.2 Objective 
The objective of this chapter was to; 
 Develop a technique for extracting diclofenac from water samples collected from 
ecotoxicity assays that is cost- and time-effective. 
 
3.3 Method development 
3.3.1 Materials 
The filters used in this study were obtained from Sartorius Biolab Products, Germany. 
The filters were made of a nylon membrane that was 4.9 cm in diameter and had a pore size 
of 0.2 µm. The filters were hydrophilic and had an adsorption rating for BSA of 100 µg/cm2. 
Milli-Q water (>18 MΩ) was used for all blanks, spiking solutions and buffers. Diclofenac 
sodium salt was obtained from Sigma-Aldrich. The solvents (MeOH, DCM, and AcN) used 
were all HPLC grade. 
3.3.2 Method outline 
The method used to extract diclofenac using nylon filters is outlined in Figure 3.1. 
The samples used in the method development were 100 mL aliquots of Milli-Q water that had 
been spiked with diclofenac standards obtained from Sigma-Aldrich to obtain concentrations 
of 500 and 0.5 µg/L. All samples were assayed in triplicate and were placed in Schott bottles, 
into which one nylon filter was added, before the bottles were covered in aluminium foil to 
protect samples from photodegradation. During incubation, samples were kept on a shaker 
table at a moderate speed. After incubation, the filters were removed and placed into an 
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amber vial and eluted using three 4-mL aliquots of MeOH which were combined. The 
resulting MeOH was evaporated to dryness at 65˚C under nitrogen and made up to a final 
volume of 1 mL in MeOH. It was then quantitatively transferred to a pre-weighed HPLC vial. 
The newly concentrated sample was then analysed using HPLC (Section 2.6.3). Results were 

























Water sample (100 mL) is taken and 
transferred to a 250 mL Schott 
bottle 
2 drops of Conc. H2SO4 are added to 
the water samples. Gently shake for 
15 seconds and leave for 30 
seconds. 
Add a nylon filter to the water 
sample and cover the bottle in foil 
to protect it from the light. 
Place the sample on a shaker table 
to a medium speed for 24 hours. 
Elute diclofenac from filter using 3x 
4 mL of MeOH 
Evaporate MeOH and concentrate in 
1 mL of MeOH. 
Analyse the sample using either 
HPLC or GC-MS 





For quality control and assurance, blanks were used. The blanks were 100 mL aliquots of 
Milli-Q water. The blanks were non-acidified in the method development and the filters were 
not dried. A blank was run with every incubation sample. The blanks were used to ensure 
there was no contamination of the water and to confirm cleaning standards were being met to 
avoid cross contamination from previous experiments. For quality assurance, replicates were 
run for each condition in triplicate. This allowed for determination of accuracy and ensured 
higher reliability in the statistical testing. 
3.4 Extraction study 
3.4.1 Incubation time 
Three different incubation periods (4, 8, and 24 hours) were investigated to identify 
the most suitable time to allow for maximum adsorption of diclofenac to the filter. The filters 
were not dried and samples were analysed at a pH of 5. The concentration of diclofenac in the 
samples was 500 µg/L and samples were prepared in triplicate as described in Section 3.3.2. 
 
3.4.2 Effect of concentration 
Concentration is important when developing an extraction method as often it can 
affect extraction efficiency. Two concentrations of diclofenac were tested in this study: 500 
and 0.5 µg/L. These concentrations were chosen because they were half of the concentration 
that was going to be used in the final method, meaning that if degradation occurred the 
method would still be valid for detecting lower than nominal concentrations. Triplicate 
samples of Milli-Q water were spiked (500 and 0.5 µg/L) and acidified before being 
incubated for 24 hours. 
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3.4.3 Filter condition 
The condition of the filter is another factor that could influence recovery of 
diclofenac. Of specific interest was the moisture content of the filter (wet versus dry). If the 
dry filter did not yield recoveries equal to or significantly greater than the wet filters then the 
method would be limited to extracting concentrations detectable at HPLC level only. This is 
because water damages the column and affects the efficiency of derivatisation (Sugaya et al. 
2001). Triplicate samples were 500 µg/L in concentration and were incubated for four hours. 
The saturated condition was leaving the filter wet for the elution phase as outlined in Section 
3.3.2. For the dry condition the filter was dried at 65°C for 3 hours before carrying out the 
elution phase.   
3.4.4 Effect of pH 
Two different pH conditions were investigated: pH 5.7 and pH 2. pH 5.7 was obtained by 
using pure Milli-Q water in equilibrium with air, and pH 2 was obtained with the addition of 
3 drops of concentrated H2SO4. After addition of the acid, samples of 100 mL volume were 
left to equilibrate for 30 seconds after being thoroughly mixed by hand, before the addition of 
the filter. The remaining method was exactly as outlined in Section 3.3.2. The effect of pH 
was only investigated for the 24 hour incubation period. All samples were run in triplicate. 





3.5.1 Effect of incubation time 
Diclofenac recovery increased with time (Figure 3.2). A recovery of 32% after four 
hours, increased to 38% after 8 hours and to 58% after 24 hours. The 24 hour extractions 
were significantly greater than the four and eight hour treatments (p = 0.0007 and 0.008 
respectively). 
Figure 3.2: Recovery of diclofenac at pH 5.7 at differing incubation times (4, 8, and 24 hours). The 
spike concentration was 500 µg/L (n = 3; mean ± SEM). Time periods sharing letters are not 
significantly different. 
 
3.5.2 Effect of pH and concentration 
As seen in Figure 3.3, the percent recovery was greater for the non-acidified samples 
for the 0.05 µg/L spike in comparison to the 500 µg/L treatment (p = 0.0017). There was no 
significant difference in recovery rates when comparing concentration and acidification (p = 
0.4442). The recovery of diclofenac was concentration-dependent. The average recovery was 






























Figure 3.3: Recovery of diclofenac at pH 2 (acidified) and pH 5.7 (non-acidified) with an 
incubation period of 24 hours. The spike concentrations were 500 and 0.5 µg/L (n = 3; mean 
± SEM). Samples sharing a capital letter are not significantly different in relation to 
concentration. Samples sharing a lower case letter were not significantly different in relation 
to pH. 
  
   
3.5.3 Effect of filter condition 
There was no significant difference in diclofenac recovery between wet and dry filters 
(p = 0.7063, Figure 3.4). The recovery rates for the wet filters was 32.19% (±) 1.43% and the 





























Figure 3.4:  Recovery of diclofenac at pH 5.7 at differing filter conditions (wet and dry). The spike 





3.6.1 Extraction method 
The application of the passive sampler method to diclofenac extraction within this 
study yielded recovery rates of 56-104% over 24 hours. There were greater recoveries 
observed at the lower concentrations which is likely due to saturation of binding sites being 
reached at a concentration lower than that of the highest tested diclofenac concentration 
(Section 3.6.5). The recovery values obtained for the 500 µg/L-spiked samples are consistent 
with those observed in literature (Table 3.1). Diclofenac has been studied intensively with 
many extraction and analytical techniques being employed to measure its concentration in a 
range of samples. The use of passive sampling with nylon filters works within the 
environmental range of concentrations (Section 1.3.2), meaning it has utility for 
environmental monitoring. This method does not, however, improve upon selectivity of 
compounds extracted as the filters used have a broad selectivity (Satorious Biolab Products, 
Germany). Another drawback is that the volume of sample required for the extraction process 





























filters to determine recovery rates at higher concentrations if this technique is to be used for 
laboratory exposures testing high concentrations. 
 
Table 3.1: Comparison of extraction and analytical techniques used when studying 
diclofenac. Recovery concentrations obtained and recovery percentages are included as a 
reference point for values obtained in this study. 













Wille et al. (2011) 
20 ng/L 105.2% 
SPE, LC-MS Diclofenac 0.055 µg/L 81% Stülten et al. (2008) 
SPE, HPLC-
UV 
Diclofenac 100 µg/L  86.5% 
 
Zhou et al. (2014) 























50 µg/L 82.7-103.5% 
 
  
                                                          
2 Supramolecular solvent-based microextraction 
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3.6.2 Effect of incubation time 
Of the three time points tested (4, 8, and 24 hours), the 24 hour incubation period 
yielded the greatest recovery. This was anticipated as there was more time for the diclofenac 
to adsorb to the filter. This was also the most practical time-period in terms of carrying out 
the extraction. This is because the samples can be put on to incubate in the morning, meaning 
there is an entire day to carry out the drying and rinsing of the filters, and the extraction of the 
diclofenac. The four-hour incubation is manageable, however it would require a 10-12-hour 
session in the laboratory to have the sample incubated, extracted, and ready for analysis. The 
8-hour incubation is the least manageable and requires the samples to be put on to incubate 
late at night so they are ready to be treated in the morning. More importantly the 4- and 8-h 
time intervals yielded poor recoveries making them impractical form the perspective of both 
time and effectiveness.  
The incubation times for this study were longer than those used in other studies where 
incubation times were 10 minutes static and 30 minutes dynamic, and 15 minutes static and 
45 minutes dynamic from spiked glass matrices and tablets respectively (Yamini et al. 2002). 
This is due to the fact this study used a passive sampler, a technique which is applicable for 
long term monitoring of environmental levels in aquatic settings. Passive samplers can be left 
in the sample environment for weeks or months (Vroblesky et al. 2001; Bao et al. 2012; Page 
et al. 2014). Due to this study investigating the concentration present in a small aliquot of 
water, the sample periods were shorter than those reported in most passive sampler studies.  
3.6.3 Effect of pH 
There was no significant difference between acidified and non-acidified samples at a 
tested diclofenac concentration of 500 µg/L. Diclofenac can exist in two forms: a neutral and 
a charged species. Lowering the pH ensures that diclofenac, which has a pKa of 4.2, is 
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present in the more hydrophobic neutral species thereby enhancing sorption (Kole et al. 2011; 
Ramos Payan et al. 2011; Racamonde et al. 2015). Acidification is included in many methods 
for diclofenac recovery found in the literature (Sun et al. 2008).   
Other studies have investigated the optimal pH for extraction of diclofenac from 
water. Al-Hadithi et al. (2011) determined the optimal pH for extracting diclofenac samples 
is pH 2, as once the pH increases, diclofenac becomes ionised and has stronger interactions 
with the water, thereby reducing extraction efficiency. At least in the small volume water 
samples in the present study, it appears that acidification is unnecessary at low 
concentrations. More research examining recovery of low concentration diclofenac samples 
at varying pH will need to be carried out to determine whether acidification of the sample has 
no impact on diclofenac recovery at higher sample volumes. If this is the case, in future tests 
it would be interesting to determine at what concentration acidification becomes detrimental 
to the recovery. 
3.6.4 Effect of drying 
The effect of drying the filter prior to extraction was investigated. There was no 
significant difference between drying the filters and leaving them saturated (Figure 3.4). 
Removing water is advantageous as it enables samples extracted using nylon filters to be 
derivatised and analysed by GC-MS, which has lower detection limits than HPLC-UV. There 
is little research that has investigated the impact of drying filters on the total recovery on 
organic contaminants in general. This is likely due to environmental concentrations being in 
the ng/L to µg/L range (Table 3.1), resulting in GC-MS analysis being the practical choice.  
Peralta et al. (2010) used nylon membrane filters to extract amiloride and furosemide from a 
pharmaceuticals mixture. The filters were dried prior to extraction of the compounds from the 
filter with no impact on total recovery. Caban et al. (2015) used a Speedisk extraction disk to 
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extract PCPPs from raw and treated drinking water. The compounds successfully extracted 
were ibuprofen, paracetamol, flurbiprofen, naproxen, ketoprofen, diclofenac, 
diethylstilboestrol, 17β-oestradiol, and oestriol. The filters were dried before extraction and 
resulted in a recovery of 80% or above for most of the pharmaceuticals extracted. Drying 
filters before extraction is a common practice when using GC-MS analysis for 
pharmaceuticals. There does not appear to be a negative impact on recovery rates due to this 
process. 
3.6.5 Effect of concentration 
The percentage recovery decreased with increasing concentration suggesting 
saturation of binding sites on the filter (Figure 3.3). Therefore, by increasing the number of 
filters used, an increase in recovery would be expected owing to the increase in available 
binding sites. Alternatively, the decrease in recovery with concentration increase could be 
due to a weakening in the diffusion gradient because of the concentration of diclofenac 
already present on the filter. Passive samplers such as the nylon filter used here, work on the 
principle of diffusion driven by a concentration gradient (Vrana et al. 2005). Equilibration of 
the compound between aqueous phase and the filter in a static test (i.e. no movement of 
concentration into or out of the solution) will impact the recovery (Booij et al. 2015).  If 
equilibration is reached between the filter and sample, there is the possibility of a plateau 
being reached in terms of sample recovery. Regarding the current study, it is possible the 
higher concentration reached equilibration due to sorption capacity being reached, whereas 
the 500 µg/L test solutions did not, due to sorption capacity being large enough to deal with 
the relatively lower concentrations of diclofenac.  
For samples that are higher in diclofenac concentration, a longer incubation period 
may be required. It is known that higher concentrations produce linear uptakes for a longer 
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period of time, due to there being a greater amount of the compound to bind to the filter 
(Allan et al. 2010). A possible solution to this would be increasing the number of filters 
present to minimise the lack of binding sites. This is a minor issue, as this concentration 
(1000 µg/L) is well above environmental levels and is only likely to be an issue with high 
laboratory exposures (Table 1.2). This issue is solved with access to other extraction methods 
available in the laboratory such as SPE. 
3.7 Conclusion 
A nylon filter-based method was developed for extracting diclofenac from water samples 
collected from ecotoxicity experiments. It was concluded that recovery was more effective at 
lower concentrations with recovery percentages of 83-103% for the 0.5 µg/L samples, 
compared to 58% for the 500 µg/L samples. It was concluded that these recovery values were 
suitable for use in the exposure study outlined in Section 2.4. However, further work is 
needed to ensure maximal recovery of the analyte from the filter. 
 
Chapter 4: Effect of diclofenac exposure on the biochemistry of 
the common bully 
4.1 Introduction 
Due to its continuous entry into the environment, diclofenac accumulates within 
waterways and yet little is known about its environmental impact (Ort et al. 2009). 
Diclofenac is a high risk of generating environmental impacts. This is due to its relatively 
high environmental concentration, its persistence, and its high biological activity, which has 
already been linked to non-target species toxicity (Swan et al. 2006b).    
As a biologically-active chemical, with target effects on human gastrointestinal, renal, 
and cardiovascular systems (Emberson 2013), there is interest in determining biological 
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effects on non-target species (Gonzalez-Rey et al. 2014). To determine the effects on non-
target species, laboratory exposures examining mechanisms of effects over both acute and 
chronic time-frames are commonly used (Mehinto et al. 2010; Stepanova et al. 2013; 
Saucedo-Vence et al. 2015). Many studies have investigated the impact of diclofenac on cells 
and embryos (van den Brandhof et al. 2010; Ribas et al. 2014), however such studies cannot 
account for whole organism factors that will influence absorption, distribution, tissue-dose, 
biotransformation, and other factors associated with complex whole animal physiology 
(Parasuraman 2011).At present, only a few species have been studied in terms of diclofenac 
impacts on non-target aquatic biota, and the results vary from study to study. Much work 
remains to build a comprehensive view of the impact of diclofenac on aquatic organisms.   
There are a number of key factors that will influence diclofenac toxicity. Exposure 
concentration is likely of greatest importance, but water chemistry may also play a role. For 
example, salinity is an environmental factor that exerts significant influence over the function 
of aquatic biota. As detailed in Section 1.3.5.2, salinity influences the physiology of 
osmoregulating animals such as fish, thus affecting the pathways of contaminant uptake, and 
the sensitivity of different toxic endpoints e.g. (Levitan et al. 1979).  Therefore, accounting 
for factors such as salinity will be important for determining the impact of diclofenac on 
biochemical function in fish.  
There is limited information available regarding diclofenac in New Zealand waters and its 
impacts on New Zealand’s aquatic species (Hughes et al. 2013). This chapter examined the 
effect of diclofenac concentration and the effect of salinity on biochemical endpoints of 
toxicity in the common bully. For the study of concentration-dependent toxicity two exposure 
levels, 0.1 and 1000 µg/L, were used to simulate an environmental and effect level, 
respectively. The environmental concentration (0.1 µg/L) is well within the range of 
diclofenac concentrations measured in waters (see Table 1.2). Importantly, this concentration 
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is also within the range where it could be easily detected via GC-MS. The effect 
concentration (1000 µg/L) was a concentration which, according to previous research, is 
known to impact biochemical function in fish (Nava-Alvarez et al. 2014), but without causing 
lethality (e.g. LC50 for carp is 70.98 mg/L; (Islas-Flores et al. 2013).  
Three key biochemical pathways were examined: a marker of oxidative damage (protein 
carbonylation); and the activity of a Phase 1 biotransformation enzyme (CYP), and the 
activity of a Phase II biotransformation enzyme, which is also strongly implicated as an anti-
oxidant (GST) (Section 1.3.4.2).To assess the CYP activity, the EROD assay was used. This 
assay is commonly used in ecotoxicological studies when determining exposure to 
contaminants (Carlsson et al. 1999; Kammann et al. 2005; Van Soest et al. 2007). The EROD 
assay is capable of measuring the increase in CYP induction, hence it’s utility as a marker of 
organic contaminant exposure. CYP enzymes are present wherever toxicants may 
accumulate, so are predominant in the liver, but also at sites of contaminant uptake such as in 
the gills, and kidneys (Liu et al. 2008; Burkina et al. 2012).  Protein carbonylation is a marker 
of oxidative damage (Osório et al., 2013, and has been commonly examined used in 
ecotoxicological studies to determine the effect of exposure of organisms to contaminants 
(Driessen et al. 2015; Magni et al. 2016). As a marker of damage protein carbonylation can 
represent either an increase in ROS, or an inhibition of anti-oxidant defence mechanisms.  
Diclofenac has been recorded as increasing protein carbonylation in the common carp 
(Cyprinus carpio) with an increase observed in blood and muscle after exposure (Gonzalez-
Gonzalez et al. 2014). Activity of glutathione-S-transferase is another commonly used assay 
when determining the effect of xenobiotic compounds (Donham et al. 2005). The GST family 
is a set of detoxification enzymes that are used in Phase II cellular detoxification (Glisic et al. 
2015). They are used within the organism to conjugate glutathione (GSH) to electrophiles to 
detoxify them until the oxidative stress has been reduced or overcome (McDonagh et al. 
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2005). Detoxification often occurs in the liver, hence the liver tissue is most commonly 
examined as it has the largest increase in concentration of detoxification enzymes (Padmini et 
al. 2009). A study investigating the impact of the NSAID naproxen saw an upregulation of 
GST after exposure to 100 µg/L of naproxen in zebrafish (Stancová et al. 2015). Exposure of 
diclofenac to the wolf fish (Hoplias malabaricus) saw an increase in GST levels in a dose-
dependent manner with exposure levels of 4 × 10− 9, 4 × 10− 8 and 4 × 10− 7 M diclofenac 
(Gröner et al. 2015). The GST assay was used as a marker opposed to SOD or CAT so that it 







 Test for a range of biochemical endpoints to determine the effect of diclofenac on 
the common bully. 
4.2 Methods 
4.2.1 General methods 
Fish (n = 70; mass = 5.83 g ± 2.55 g) were collected in mid-August/late September, 
during late winter, early spring (spawning season), as per the protocol outlined in Section 2.1.  
Fish were allocated to one of two exposure scenarios.  The first tested the effects of increased 
concentration of diclofenac in freshwater and was performed in mid-August/early September. 
The second examined the effect of salinity on diclofenac toxicity and was carried out late 
September/early October. Owing to the timing of the exposures, some of the fish used were 
pregnant females.  
4.2.1.1 Concentration-dependent exposure 
The concentration-dependent exposure examined the effects of two diclofenac 
concentrations (0.1 µg/L, environmental mimic; 1000 µg/L, effect level) relative to a control 
(0 µg/L). Three stock solutions were prepared. A 500 mg/L solution was prepared by 
dissolving 0.1345 g of diclofenac in 250 mL of Milli-Q water. The 500 mg/L stock was 
diluted with Milli-Q water to prepare 10 mg/L and 50 µg/L spiking solutions. The 500 mg/L 
and the 50 µg/L solutions were added to 2 L of water in 4 mL volumes to obtain final 
concentrations of 1000 µg/L and 0.1 µg/L respectively. The stock solutions were prepared at 
the start of the concentration dependent exposures and used throughout until the end of the 
salinity dependent exposures. Diclofenac was added to exposure waters 24 hours before fish 
were added to ensure equilibrium. Each concentration had an n = 8 (n is the number of fish), 
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with 1 fish per exposure tank. Full details of the experimental methods are reported in Section 
2.2.  
4.2.1.2 Salinity-dependent exposure 
These experiments were conducted under the same environmental conditions to those 
described in Section 2.4.2, with the exception of the salinity of the exposure water (0‰, 6‰ 
and 20‰) and diclofenac concentrations examined (0 and 1000 µg/L). The water chemistry 
and salinity acclimation protocol are outlined in Section 2.2. The 96 h exposure was 
conducted identically to those described for concentration-dependent exposures (Section 
2.4.2), with stock solution handling (Section 2.4.1), water pre-equilibration, water changes, 
and water sampling for diclofenac conducted as previously detailed (Section 2.4.2).   
4.2.2 Tissue sampling  
At the conclusion of the exposures, fish were euthanised and dissected as per the 
protocol in Section 2.4.4. For analysis of the effect of diclofenac on the common bully, two 
tissue samples were used in the biochemical assays: gill and liver. The gill tissue was used to 
measure the rate of CYP activity in units of pmol resorufin/filament tip/h as per the protocol 
outlined in Section 2.5.1. The liver was used to measure protein carbonylation in units of 
nmol carbonyl/mg protein and GST activity in units of µmol/mg protein/minute. Protocols for 
both the protein carbonylation and the GST assays can be found in Sections 2.5.3 and 2.5.2, 
respectively. 
4.2.3 Statistical analysis 
For some assays some samples did not record any activity for the biochemical endpoint 
being measured. Where this occurred, these values were discarded, on the basis that even in 
control tissues all of these assays should provide a measurable value. Thus a non-detectable 
value (which occurred evenly among exposure concentrations) likely represented an assay 
51 
 
failure, rather than an actual zero value.  Furthermore, any outliers that were more than two 
standard errors away from the mean, were excluded from analysis. All final n values for 
biochemical assays are reported in Table 4.1.  
Table 4.1 Final n values for fish used in biochemical assays (EROD, PC, GST) at varying 
salinities and diclofenac concentrations. The mean weight (±) SEM of the fish is included. 
Salinity (ppt) Concentration 
(µg/L) 
Mean SEM n 
0 0  4.51  1.26 7 
 0.1 7.99 1.48 6 
 1000 6.23 3.30 6 
6 0 5.46 2.12 7 
 1000 4.90 3 8 
20 0 5.09 1.13 7 
 1000 5.91 1.52 8 
 
Statistics were run using Sigmaplot (ver.11.2; Systat). Data were tested for normality 
using the Kolmogorov-Smirnov test and homogeneity of variance using Levene’s test. Any 
data that failed one of these tests were transformed via either log- or square root-
transformation. This transformation resulted in the assumptions of parametric analysis being 
fulfilled. All data were then subjected to a one-way ANOVA (concentration-dependence) or a 
two-way ANOVA (salinity-dependence; with salinity and concentration as the two factors), 
with a post-hoc Tukey’s test.  Some data-sets (specifically EROD activity and protein 
carbonylation in the concentration-dependent study) showed high variability in the highest 
exposure concentration. In these cases, in addition to the ANOVA, an unpaired Student’s t-
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test was performed to act determine significance between specific exposure concentrations. 
This was used only as a guide, and was not considered the definitive statistical approach. 
4.3 Results 
4.3.1 Exposures 
4.3.1.1 Concentration-dependent exposure 
Figure 4.1 represents the measured diclofenac exposure concentrations from the 
concentration-dependent exposures. There was an average recovery of 0.10 µg/L for the 0.1 
µg/L exposure group and an average recovery of 380 µg/L for the 1000 µg/L group. 
Degradation is observed across the 1000 µg/L test group with higher concentrations observed 
at 0 and 48 hours (after the water change), and lower recoveries observed at 48 hours (before 
the water change) and 96 hours. The 0.1 µg/L test showed consistent recoveries at each time 
point with the exception of a spike at 48 hours (before the water change).  There was no 











Figure 4.4: Measured diclofenac concentrations in exposure water over the course of 96 
hour exposures with spiking concentrations of 0.1(a) and 1000 µg/L (b). Plotted points 
represent mean values (± SEM) of n = 5-8 replicates, where each replicate represents the 
































































4.3.1.2 Salinity-dependent exposure 
Figure 4.2 shows the measured diclofenac exposure concentrations from the salinity-
dependent exposures. There was a mean recovery of 232 µg/L, 645 µg/L, and 644 µg/L for 
the 0‰, 6‰, and 20‰ salinities respectively. A one-way ANOVA showed there was no 
significant difference in exposure concentrations between salinities (p = 0.146). There was no 
detectable diclofenac in the control exposures (data not shown). 
 
Figure 4.5: Measured diclofenac concentrations in waters of varying salinity over the course 
of 96 h exposures at a nominal exposure concentration of 1000 µg/L. Samples represent 
mean (± SEM) of the average of four samples taken at various times from three replicate 





































4.3.2 Biochemical assays 
4.3.2.1 Glutathione-S-transferase assay 
Diclofenac had no significant effect on liver GST activity as determined by a one-way 
ANOVA (p = 0.349). However, the large variability noted in the 1000 µg/L exposure group 
likely precluded significance. Therefore, an unpaired Student’s t-test was performed which 
re-enforced the one-way ANOVA resulting in no significant difference between the control 
and the 0.1 µg/L exposure concentrations (p = 0.115).  
  
Figure 4.6: Effect of diclofenac exposure concentration on GST activity in the liver of 
common bullies exposed for 96 h. Plotted points represent means (± SEM) of 5-7 replicates. 
 
 
Figure 4.4 shows the impact of salinity and diclofenac concentration on GST activity. The 














































salinity on GST activity (p = 0.733) and there was no overall significant effect of diclofenac 
exposure concentration on activity (p = 0.829). Similarly, no effect of the interaction between 
these two factors was observed (p = 0.505). 
Figure 4.7: Effect of salinity on GST activity in the liver of common bullies exposed to 
diclofenac for 96 h. Plotted points represent means (± SEM) of 8 replicates. 
 


















































4.3.2.2  EROD assay 
Figure 4.5 shows the impact of increasing diclofenac concentration on EROD activity 
in the gills of the common bully. Diclofenac had no significant effect on gill CYP activity as 
determined by a one-way ANOVA (p = 0.151). However, there was a large variability noted 
in the 1000 µg/L exposure group, which may have precluded significance. Therefore, an 
unpaired Student’s t-test was performed, which did highlight a significant difference between 
the control and 0.1 µg/L exposure group (p = 0.021). The t-test did not detect any significant 
difference between the control and the 1000 µg/L group (p = 0.145), nor between the 0.1 and 
1000 µg/L groups (p = 0.482). 
Figure 4.8: Effect of diclofenac exposure concentration on EROD activity in the gills of 
common bullies exposed for 96 h. Plotted points represent means (± SEM) of 3-5 replicates. 
 
Figure 4.6 shows the relationship between salinity and diclofenac effects on EROD 











































concentration (p = 0.543) on activity. Similarly, no effect of the interaction between these 
two factors was observed (p = 0.843).  
Figure 4.9: Effect of salinity n on EROD activity in the gills of common bullies exposed to 
diclofenac for 96 h. Plotted points represent meanss (± SEM) of 6-7 replicates. 
 
4.3.2.3 Protein carbonylation assay  
Figure 4.7 shows the relationship between diclofenac concentration and protein 
carbonylation in liver tissue. Statistical testing via one-way ANOVA did not yield a 
significant outcome (p = 0.199), but as with the EROD results, there was a high variance. A t-
test did produce a significant difference between the 0 and 1000 µg/L groups with a p value 











































Figure 4.10: Effect of diclofenac exposure concentration on protein carbonylation in the liver 




 Figure 4.8 highlights the effect of salinity on the impacts of diclofenac on protein 
carbonylation in liver tissue. Statistical analysis did not yield any significant effects of 
diclofenac concentration (p = 0.448), salinity (p = 0.442) or the interaction between salinity 











































Figure 4.11: Effect of salinity on protein carbonylation in the liver of common bullies 




4.4.1 Diclofenac exposure concentrations 
In the concentration-dependent study there was an average recovery of 0.10 µg/L for 
the 0.1 µg/L exposure group and an average recovery of 380 µg/L for the 1000 µg/L. The 
much lower than targeted exposure concentration in the high exposure group could reflect 
one of three possibilities. The first is that the fish themselves took up diclofenac leading to a 
decrease in exposure concentration. This is unlikely as the same pattern was not observed at 
the lower concentration, and previous work has shown that at lower exposure levels, relative 














































photodegradation. Diclofenac is known to degrade upon exposure to light (Buser et al. 1998), 
but under the current exposure conditions this was minimised by conducting the experiments 
in the dark. The third possibility is that the exposure concentrations were relatively accurate, 
but the recovery method used to measure these provided a lower-than-dosed concentration. 
As detailed in Chapter 3, the passive filter-based method of assaying diclofenac used in the 
current study, is relatively poor at recovering diclofenac from waters with high 
concentrations (such as the 1000 µg/L exposure concentration used here; see Table 4.1). This 
is the most likely explanation for the relatively low measured diclofenac concentration in the 
current study.   
4.4.2 Salinity-dependent exposure 
Diclofenac has an environmental presence in both fresh and saline waters (Table 1.2). 
There is much literature examining the influence of salinity on toxicant effects in aquatic 
biota. For example, salinity generally has a significant protective effect on trace metal 
toxicity (Bielmyer et al. 2010). This is in part due to the change in metal ion speciation (from 
their toxic, ionic forms to forms that are less bioavailable), but also because of differences in 
the physiology of biota at different salinities (Bielmyer et al. 2010). One key difference in 
physiology is drinking. In high salinity settings, where the external osmolality is greater than 
internal osmolality, fish drink in order to regain water lost by diffusion (Evans et al. 2004). 
This means that the gut could be a potential uptake pathway for diclofenac, increasing body 
burden, and thus increasing the toxic impacts of this drug. A previous study examining the 
organic toxicant naphthalene, showed this exact pattern, with increased tissue levels and toxic 
effects in killifish at higher exposure salinities (Funduls heteroclitus); Levitan and Taylor 
1979).  However, in the current study, there was no evidence of this effect. Future studies to 
examine tissue diclofenac burden would be required in order to determine whether the lack of 
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response was due to a lack of additional tissue uptake, or a lack of toxicological impact of the 
additional body burden.  
There has been little previous work examining the impact of salinity on diclofenac 
toxicity. However, the research that has been done found similar outcomes to those described 
here. For example, there was no effect of salinity on diclofenac toxicity (survival, 
development) to the estuarine shrimp Palaemon longirostris (González-Ortegón et al. 2016), 
while in the crab Carcinus maenas, salinity did not alter the outcome of a diclofenac-
mediated impact on osmoregulatory capacity (Eades et al. 2010).  
Future work should consider examining ionoregulatory effects of diclofenac exposure 
on common bullies. Exposure of other NSAIDS (ibuprofen, salicylate) has been shown to 
impair corticosteroidogenesis in rainbow trout, an effect which will impact the acclimation of 
this species to seawater (Gravel et al. 2009). Furthermore, the exposure of fish to diclofenac 
leads to gill damage (Schwaiger et al. 2004; Hoeger et al. 2005; Memmert et al. 2013) which 
could also impair the ability of fish to osmoregulate.  
It is worth noting that salinity had no effect on biochemical measures even in control 
tissues. There is evidence that EROD activity, GST activity, and protein carbonylation can all 
be influenced by salinity alone, independent of the presence of a toxicant (Donham et al. 
2006; Amutha et al. 2010; Blewett et al. 2015). However, this depends on the species tested 
e.g. (Jönsson et al. 2003; Fonseca et al. 2011). It appears that enzyme measurements in 
common bully are relatively resistant to salinity. This is positive from the perspective of 
environmental monitoring, as it means that measurements will not be impacted by 
environmental factors, a characteristic of a good biomarker (van der Oost et al. 2003). 
However, the lack of toxicant-responsiveness suggests that the common bully may not be the 
most sensitive fish species. This is consistent with previous data that show the common bully 
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was among the most tolerant of tested native New Zealand freshwater fish species to hypoxia 
(Landman et al. 2005). 
4.4.3 Effects of diclofenac on GST  
 
 Glutathione S-transferase has two key roles in toxicology. It is a biotransformation 
enzyme that is used to detoxify both endogenous and exogenous compounds (Kim et al. 
2010), but is also an important anti-oxidant by virtue of the fact that it detoxifies pro-oxidant 
contaminants, and pro-oxidant products formed by Phase I metabolism (Sharma et al. 2004). 
For this reason GST is often used as an indicator of an organism’s exposure to a toxic 
compound (Kim et al. 2010). GST has been shown to play a role in diclofenac metabolism 
(Dragovic et al. 2013), and thus diclofenac exposure would be expected to increase GST 
activity in common bully, as has been previously reported for other fish (e.g. common carp; 
Stepanova et al. 2013). In the current chapter, no effect of diclofenac on GST was observed.  
There are a number of possible explanations for this. The levels of diclofenac taken 
up by the common bully may not have been high enough to elicit a response. Further work 
examining diclofenac in common bully tissue would be useful in determining the 
effectiveness of diclofenac uptake by this fish.  It is also possible that other components of 
the oxidative stress cascade may be assisting in the scavenging of ROS preventing 
upregulation of GST. This is supported by a study that showed GST activity actually 
decreases in the liver of wolf fish (Holplias malabaricus) exposed to diclofenac (Guiloski et 
al., 2015). Although GST activity went down, there was an increase in the activity of 
superoxide dismutase, total glutathione and glutathione peroxidase activity. This implies that 
the ROS scavenging of these three important antioxidant components, may have been 
sufficient to have caused a decrease in GST activity.   
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It is clear, however, that there are contrasting outcomes regarding the effect of 
diclofenac exposure on GST activity. As mentioned above, a study on early life-stages of the 
common carp (Cyprinus carpio) showed induction of GST activity (Stepanova et al. 2013), 
while in wolf fish GST activity decreased (Guiloski et al., 2015). Praskova et al. (2014) 
described diclofenac at a concentration of 0.2 mg/L, as having no effect on GST activity in 
the zebrafish (Danio rerio), while Ghelfi et al. (2016), did not observe any significant effect 
up to a concentration of 20 µg/L in catfish (Rhamdia quelen). It seems likely that there are 
species differences in GST responsiveness to diclofenac, although differences in exposure 
concentration, life-stage of the exposed animal, and exposure duration, may also be 
important.   
4.4.4 The effects of diclofenac on CYP activity 
The exposure of Gobiomorphus cotidianus to diclofenac, was expected to result in an 
increase in CYP activity. Diclofenac binds to the  aryl-hydrocarbon receptor activating it and 
inducing CYP1A in tissues including the gills (Jönsson et al. 2003). The results of the 
ANOVA suggested that there was no statistical significance effect of diclofenac 
concentration on EROD activity in the current study. However, the large variation in EROD 
activity values in the highest exposure group likely precluded significance. Subsequently, a 
Student’s t-test showed that at the environmental exposure level (0.1 µg/L) a significant 
increase in EROD activity existed, relative to the control. Conducting multiple t-tests instead 
of an ANOVA is not statistically valid, unless there is a multiple comparisons correction. 
When a Bonferroni correction was applied (alpha level/number of comparisons = new alpha 
level of 0.017), the p value for the comparison still narrowly eluded significance (0.021). 
Nevertheless, there is sufficient evidence to suggest that there is a non-significant trend of 
increased EROD activity with diclofenac exposure in the gills of common bully.  
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It is possible this variation within groups was due to the timing of fish collection. The 
fish used in the exposures were caught just prior to mating season. There is evidence 
suggesting male fish have higher EROD activity than females (Wunderlich et al. 2015), and 
that female EROD levels increase in late Spring/early Summer (Sole et al. 2002; Gungordu et 
al. 2011). This suggests that a mixture of male and female fish in the highest exposure group 
may have contributed to the variability. It is also worth noting that fish in the salinity-
dependent exposure had EROD activity levels that differed from the identical exposure 
concentration in the concentration-dependent study. This may have been related to the small 
differences in the timing of these two exposures as it relates to spawning season. These 
differences highlight the importance of time-matched controls (as used in the current study), 
to ensure that factors such as reproductive status are accounted for within each experiment. 
The finding of an upwards trend in EROD activity is consistent with the bulk of fish 
literature regarding diclofenac effects. After exposure to 1 µg/L of diclofenac for 14 days and 
2 mg/L of diclofenac for 24 hours, induction of EROD activity occurred in the three-spined 
stickleback (Prokkola et al. 2015). Diclofenac exposure at a concentration of 100 µM also 
induced EROD activity in European seabass (D. labrax; (Ribalta et al. 2014). However, there 
are some data that suggests diclofenac causes an inhibition of EROD activity. This has been 
observed in rainbow trout hepatocytes at concentrations of 22-940 µM (Laville et al. 2004), 
and following whole animal exposures to 100 µM diclofenac in the Mediterranean fish 
species Trachyrynchus scabruss (Ribalta et al. 2014). Inhibition of EROD activity in these 
studies is thought to be due to excess formation of ROS that inhibit CYP enzymes at the 
transcriptional or post-transcriptional level through inhibition and degradation of mRNA 
(Smutny et al. 2013). It is therefore possible that the lack of a truly significant EROD effect 
in the current study may be a consequence of mixed stimulatory and inhibitory effects on gill 
EROD activity in the common bully.  
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4.4.5 Effect of diclofenac on protein carbonylation 
The results of a one-way ANOVA showed that there was no effect of diclofenac on 
protein carbonylation in the liver of the common bully. When conducting a t-test a p value of 
0.040 was obtained when comparing the 0 and 0.1 µg/L groups but this value was again 
above the Bonferroni corrected alpha value of 0.017. Nevertheless, there was a statistical 
trend towards an increase in protein carbonylation with diclofenac exposure.   
An increase in protein carbonylation has been reported in previous studies examining 
diclofenac toxicity in fish. For example, (Saucedo-Vence et al. 2015) measured a significant 
increase in protein carbonylation across five tissue types in the common carp (Cyprinus 
carpio) at diclofenac concentrations of 7 mg/L. Diclofenac exposure also resulted in 
increased protein carbonylation in the aquatic sediment-dwelling bioassay amphipod Hyalella 
azteca (Oviedo-Gomez et al. 2010), and also in the common carp (Nava-Alvarez et al. 2014). 
Coupled with the nearly significant results in common bully, protein carbonylation in 
response to diclofenac exposure appears to offer the most consistent results of all the tested 
endpoints in the current study. As such protein carbonylation is likely to be the endpoint with 
the most utility as a biomarker of diclofenac effect in aquatic organisms.  
4.5 Conclusion 
In summary, there were no statistically valid significant effects of diclofenac on any of 
the measured biochemical end-points in the common bully. This was probably due to high 
variability in some exposure groups, likely a result of having mixed sex fish, and variability 
in reproductive status. The trends in the data do, however, agree with the bulk of existing 
literature, and suggest that mechanism of diclofenac toxicity are likely to be conserved in the 
common bully. However, further work on fish outside of spawning season would be required 














5  Overview 
Diclofenac is a widespread contaminant within global waterways, generating concern 
regarding its toxicity to aquatic species (Fent et al. 2006). However, prior to this thesis there 
was no research that explored the possibility of diclofenac generating toxic effects in New 
Zealand bullies. Consequently, this thesis had two aims. The first was to develop a simple 
and cost-effective method for extracting diclofenac from water that would facilitate the 
measurement of environmental and laboratory concentrations of diclofenac (Chapter 3).  The 
second was to examine diclofenac toxicity on the native New Zealand fish species, the 
common bully, by investigating changes in key biochemical pathways (Chapter 4).  
Chapter 3 details the development of a passive sampling technique for the extraction of 
diclofenac from water samples from ecotoxicity experiments. Many studies use a form of 
solid phase extraction or liquid-liquid extraction (Rezaei et al. 2013; Ji et al. 2014; Zhou et al. 
2014; Toledo-Neira et al. 2015), however passive sampling is an upcoming technique for 
monitoring environmental levels of pollutants in large bodies of water (Joyce et al. 2015). 
Passive sampling techniques allow for real-time collection of environmental concentrations, 
and critically are both time- and cost-effective (Nyoni et al. 2010).  In this thesis, the 
developed method involved the placement of a simple nylon filter in a collected water 
sample, which was left for 24 h for adsorption to occur. Thereafter, the sample could be 
extracted and analysed via either HPLC or GC-MS, depending on the requisite detection 
limit. This technique was found to be highly effective for recovering diclofenac from waters 
where it was present at low concentrations. At a concentration of 0.05 µg/L, recovery rates 
for diclofenac were 103%. This result indicates that this technique could have significant 
value for environmental monitoring of diclofenac concentrations.  
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A key drawback to the method was its inability to adequately deal with high diclofenac 
concentrations, such as those used as the “effect level” in the diclofenac exposures conducted 
in Chapter 4. It was likely that the filter was saturated by the high concentrations, meaning 
that the recovery was poor (58%). However, this is a problem that could likely be overcome 
by increasing the adsorptive surface, by adding filters to the water sample.  
Overall, therefore the developed technique was successful. It offered a proof-of-concept 
for nylon-based filter extraction of diclofenac for water samples from ecotoxicity assays. It 
was a time- and cost-effective method, and facilitated high throughput of samples. 
Importantly it was a technique that was compatible with both HPLC and GC-MS.  
It is, however, worth noting that there were issues regarding contamination when using 
the GC-MS for analysis of 0.1 µg/L water samples.  Because each sample had to be run for 
approximately 22 minutes before any peak could be observed, a high concentration standard 
was run beforehand to ensure correct positioning of the peak and reference ions. This resulted 
in carry-over from the standard to the first batch of samples. This carry-over meant the 
samples were unable to be used, reducing the total number of usable samples. Once the issue 
had been identified, the arrangement of standards and samples were corrected and the final 
concentrations obtained were in line with the hypothesis. It did mean that for the 0.1 µg/L 
samples the total sample group was smaller than originally planned, which may have 
impacted statistical significance. 
To investigate the possibility of diclofenac causing toxic effects in New Zealand aquatic 
species, the common bully was chosen as an experimental organism. This fish species is 
native to New Zealand, has a widespread geographical distribution (Vanderpham et al. 2013), 
and has been previously used in studies for assessing environmental impact of toxicants (van 
den Heuvel et al. 2007). In addition to examining the effect of diclofenac concentration, the 
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effect of salinity on toxicity was also investigated. The common bully is also an ideal species 
in which to examine this environmental factor as it is a facultatively diadromous species 
living part of its lifecycle in freshwater and part in salt water, and as such is tolerant to 
salinity changes  (Bleackley 2008). However, in contrast to expected changes, biochemical 
analysis of the common bully after exposure to varying concentrations of diclofenac (0, 0.1, 
and 1000 µg/L) and varying salinities (0, 6, and 20‰) yielded no significant results with 
respect to EROD activity, GST activity and protein carbonylation. This was due in part to 
high variability, at least in the case of EROD activity and protein carbonylation. This 
variability likely resulted from the presence of mixed sex exposures, and the coincidence of 
the exposure with reproductive cycles, which are known to impact these measures (Sole et al. 
2002; Gungordu et al. 2011; Wunderlich et al. 2015). Pairwise statistical analysis did show 
non-significant trends towards increases in EROD activity and protein carbonylation. 
Coupled with literature reports of biochemical changes in fish and other aquatic biota 
exposed to diclofenac, the results of Chapter 4 suggest that the mechanism of diclofenac 
toxicity is likely to be conserved in the common bully. This analysis also suggests that 
protein carbonylation is likely to be the most informative biomarker of diclofenac exposure, 
as it is the endpoint that changes the most consistently, in contrast to the other two 
biochemical end-points that vary in terms of the directionality of the effects (i.e. both 
increases and decreases of activity have been reported).  
That mechanisms of toxicity appear to be conserved in common bully indicates that, in 
general, regulatory tools for diclofenac that have been developed to protect biota 
internationally will be applicable to this species. Importantly, the end-points of toxicity 
measured in this study seem to be unimpacted by salinity, suggesting that this will not be an 
important factor that could give “false positives”. However, the statistical outcomes make it 
difficult to determine the true sensitivity of the common bully to diclofenac. It is possible that 
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they are not a good biomonitoring or sentinel species as they may be relatively tolerant to 
diclofenac. Future work should examine the impacts of diclofenac across a range of other 
native aquatic biota. Of particular interest will be the galaxiid fish. Like the common bully, 
this group of fish species are native to New Zealand, and occupy many of the same waters as 
do common bullies (McDowall 2006). However, in some studies conducted to date, they 
appear to be more sensitive to environmental stressors (Landman et al. 2005). Previous 
studies (Section 1.5.2) support the use of the common bully for environmental toxicology 
research. The common bully has a proven history of responding to environmental toxicants 
and inhabits areas that have exposure to pollutants. This makes it a useful test subject for the 
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